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ABSTRACT OF DISSERTATION 
 
 
 
 
GENETIC REGULATION OF HEMATOPOIETIC STEM CELL AGING 
 
It is well documented that both quantitative and qualitative changes in the murine 
hematopoietic stem cell (HSC) population occur with age.  In mice, the effect of aging on 
stem cells is highly strain-specific, thus suggesting genetic regulation plays a role in HSC 
aging. In C57BL/6 (B6) mice, the HSC population steadily increases with age, whereas in 
DBA/2 (D2) mice, this population declines.  Our lab has previously mapped a 
quantitative trait locus (QTL) to murine chromosome 2 that is associated with the 
variation in frequency of HSCs between aged B6 and D2 mice.   In these dissertation 
studies, I first aim to characterize the congenic mouse model which was generated by 
introgressing D2 alleles in the QTL onto a B6 background.  Using a surrogate assay to 
mimic aging, I analyzed the cell cycle, apoptotic and self-renewal capabilities of 
congenic and B6 HSCs and show that D2 alleles in the QTL affect the apoptotic and self-
renewal capabilities of HSCs.  In the second aim of these studies, I used oligonucleotide 
arrays to compare the differential expression of B6 and congenic cells using a population 
enriched for primitive stem and progenitor cells.  Extensive analysis of the expression 
arrays pointed to two strong candidates, the genes encoding Retinoblastoma like protein 1 
(p107) and Sorting nexin 5 (Snx5).  B6 alleles were associated with increased p107 and 
Snx5 expression in old HSCs therefore both genes were hypothesized to be positive 
regulators of stem cell number in aged mice.   Finally, in the third aim of these studies, I 
show that the individual overexpression of p107 and Snx5 in congeic HSCs increases 
day35 cobblestone area forming cell (CAFC) numbers, therefore confirming their roles as 
positive regulators of HSC number in vitro.  These studies uncover novel roles for p107 
and Snx5 in the regulation of HSC numbers and provide additional clues in the complex 
regulation of HSC aging. 
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 CHAPTER ONE  
 
Introduction 
 
Properties of Hematopoietic Stem Cells and Organization of the HSC Hierarchy 
Hematopoietic stem cells (HSCs) are described conceptually as pluripotent cells 
with the potential to generate all of the mature blood cells in the body over the lifetime of 
an organism.  In the early 1960s, Siminovitch et al. provided what remain today the two 
functional criteria for defining HSCs:  the capacity for multi-lineage differentiation and 
the ability to self-renew to give rise to more HSCs (Siminovitch et al., 1963; Till and 
Mccullough, 1961). Adult hematopoietic stem cells comprise approximately 0.01% of the 
bone marrow compartment in which they reside, yet they are responsible for the 
continuous replenishment of mature blood cells lost through attrition and routine somatic 
cell aging (Geiger and Van Zant, 2002).   A delicate balance between self-renewal, 
differentiation, and cell death must be maintained to ensure not only hematopoietic 
homeostasis, but also organismal homeostasis and longevity.   
 Mouse HSC populations have been subdivided into three populations 1) long-term 
HSCs (LT-HSCs), which have extensive self-renewal capacity, 2) short-term HSCs (ST-
HSCs), which have a limited self-renewal capacity, and 3) multipotent progenitor cells, 
which do not self-renew and ultimately differentiate into either myeloid or lymphoid 
precursor cells (Figure 1.1).  Thus the differences in developmental potential and the 
linear relationship of stem and progenitor cells represent a well-established biological 
hierarchy.  LT-HSCs possess high proliferation potential and can generate all eight 
mature hematopoietic lineages: B and T lymphocytes, erythrocytes, 
megakaryocytes/platelets, basophils/mast cells, eosinophils, neutrophils, and 
monocytes/macrophages (Szilvassy, 2003).  In mice, a single LT-HSC can regenerate and 
maintain the hematopoietic system of an irradiated host, demonstrating the extensive 
proliferation and long-term multi-lineage reconstituting activity of this primitive cell 
population (Osawa et al., 1996).  Multipotent progenitor cells give rise to clonogenic 
cells that are able to differentiate into cells of a single hematopoietic lineage (Abramson 
et al., 1977).   Common lymphoid progenitors possess a lymphoid-restricted capacity and 
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produce B and T cells and natural killer cells (Kondo et al., 1997), while common 
myeloid progenitors give rise to megakaryocyte/erythrocyte or granulocyte/macrophage 
cells (Akashi et al., 2000).  A small reserve of HSCs carry the burden of replenishing 
millions of mature cells daily throughout the lifetime of an individual in order to prevent 
immunosenescence or aplasia. There is no compelling evidence that stem cell reserves 
decline sufficiently in old age to threaten adequate blood cell production (Rando, 2006).  
However, studies do indicate that aged tissues have a diminished capacity to return to a 
homeostatic state after exposure to stress or injury, therefore indicating a defect in stem 
cell function during the aging process.  Since the HSC population provides an ideal 
model to study stem cell aging, it is necessary to elucidate the mechanisms of 
hematopoietic aging and expand the findings to other tissues and organ systems. 
 
Theories of Aging and Age Related Epigenomic Changes 
There are two major theories of organismal aging: evolutionary and damage 
based.  The former suggests that natural selection favors a genetic composition that 
enhances reproductive fitness and fecundity.  According to the theory, since the effect of 
this genetic repertoire on vitality following the reproductive lifespan is immaterial to the 
propagation of the species, genes have been selected and accumulated which favor 
reproductive success but have negative effects later in life, thus limiting lifespan.  Simply 
put, aging genes have not been selected based on their value for fitness, but are most 
likely by-products of evolution (Vijg and Suh, 2005).  This idea has been termed 
antagonistic pleiotrophy, and can be used to explain how genetic traits can have both 
beneficial and deleterious effects for a species (Campisi, 1997).  Campisi and others 
propose that cellular senescence, for example, is antagonistically pleiotropic, suggesting 
that the senescence response is a selected phenotype that prevents cancer during early 
life, while at later times contributes to age related pathologies (Campisi, 1997; Krtolica 
and Campisi, 2002). The second theory of aging argues that accumulated cellular damage 
over a lifetime limits the effective functioning of key organ systems.  Poorly repaired 
damage of chromosomal DNA, stress-related aberrations in structural enzymes or protein 
turnover, and/or deletions in mitochondrial DNA, for example, may compromise organ 
function and in turn limit longevity.  Given the extremely complex phenotype of aging, 
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numerous other theories such as the free radial theory of aging (Harman, 1956) and 
protein damage accumulation theory (Levine, 2002) have been postulated in an attempt to 
explain what aging is and why it happens.  A common theme among many of these 
theories is to take a reductionist approach and focus attention at the molecular level in 
hopes of understanding the aging of organisms through the aging of their components.  In 
our quest to understand the aging process, we must face reality and succumb to the notion 
that aging is a multifactorial process; therefore it’s likely that all of the aforementioned 
processes factor into this phenomenon.  
 An important theme emerging in the field of aging research is the role of 
epigenetic alterations in aging mammalian tissues.  As mentioned above, genetic 
instability in the form of direct DNA mutations, translocations, and/or deletions has been 
proposed to accumulate with age.  However, studies reveal that there is yet another class 
of heritable DNA alterations that are not associated with direct changes in primary 
nucleotide sequences.   These epigenetic changes can alter gene expression patterns 
simply by treating the same sequence of DNA differently at the level of the individual, 
organ, cell lineage or even differentiation state (Mager and Bartolomei, 2005).  
Epigenetic modifications, most commonly in the form of changes in the methylation 
status of DNA and biochemical modifications of core histones, have been linked to the 
aging process and are increasingly recognized as part of normal and pathologic aging 
physiology (Issa, 2003).  Manel Esteller’s group studied the epigenetic profiles of 80 
pairs of monozygotic twins ranging in age from 3-74 years old and found that older twins 
exhibited large differences in their overall content and distribution of 5-methylcytosine 
DNA and histone acetylation compared to young twins which were largely 
indistinguishable epigenetically (Fraga et al., 2005).  The epigenetic changes that 
accumulated with age had a dramatic effect on gene expression, thus the authors propose 
that a so-called “epigenetic drift” accompanies the aging process.   Epigenetic 
modifications can result in the cumulative loss of gene regulation over time, ultimately 
impairing cellular and tissue function.  Further, recent data suggest that epigenetic 
disruption of tissue specific stem and progenitor cells may play a role in cancer 
development (Feinberg et al., 2006).  The correlation between aging and loss of 
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epigenetic control is consistent with the established connection between aging and cancer 
(Figure 1.2). 
 
HSCs as a Model for Stem Cell Aging 
When studying aging it is important to choose an appropriate model system.  For 
instance, cells (such as skin and blood) that undergo continuous turnover are removed 
from circulation long before they have time to feel the effects of aging, and certainly long 
before they could exert an effect on tissue function.  The predominant substrates for 
aging, thus it seems, would be long-lived cells in the organism, namely tissue specific 
stem cells, since this population is exposed to both intrinsic and extrinsic effectors of 
aging throughout the lifespan of an individual.  Within the last several years, stem cells 
have been discovered in a growing list of adult tissues.  There is new-found appreciation 
that cell turnover and tissue replacement are not the sole province of the hematopoietic 
system, the gut lining, and the skin as had been the dogma for many years (Potten and 
Loeffler, 1990).  The limited lifespan of somatic cells implies that a constant replacement 
of aged cells must occur in order for any tissue to maintain its optimal function.  With 
this in mind, it has been hypothesized that the aging or functional failure of tissue-
specific stem cells, which fulfill this job, may limit tissue repair and renewal, therefore 
contributing to overall organismal aging (Krtolica, 2005; Van Zant and Liang, 2003). 
Because of the unprecedented experimental model systems that are available for the 
exploration of HSCs, stem cell aging research in the field of hematology has been the 
subject of extensive studies.  Indeed, the hematopoietic system has served as an important 
model for advancing our understanding of stem cell biology and its association with 
aging.  It is likely that the same broad concepts that define and characterize blood-
forming stem cells will apply to stem cell populations found elsewhere.  In view of the 
importance of HSCs for maintaining immune function (preventing immunosenescence) 
and in a broader sense tissue homeostasis and longevity, there is a critical need to better 
understand the mechanisms involved not only in HSC aging, but aging in other stem cell 
compartments as well.        
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Evidence for HSC Aging 
Despite their ability to self-renew and maintain steady-state hematopoietic 
function in aged mice and humans, a close examination of the available data shows that 
age-related changes in the HSC population do occur, ultimately resulting in a decline in 
stem cell function (Harrison, 1972; Rothstein, 1993).  For example, when testing HSC 
function in vivo using competitive repopulation experiments in which the repopulating 
ability of HSCs is tested in irradiated recipients, adult bone marrow has a decreased 
ability to repopulate myeloablated recipient mice compared to fetal liver (Harrison et al., 
1997). Also, Kim et al. observed a defect in B-cell engraftment and a differentiation 
pattern skewed toward the myeloid lineage in recipients of transplants from old HSC 
donors compared to young donors (Kim et al., 2003).   In agreement with this finding, 
microarray analyses comparing the gene expression profile of young and old HSCs 
showed a marked upregulation of myeloid-associated genes and downregulation of 
lymphoid genes with age (Rossi et al., 2005).  Indeed the increased propensity of HSCs 
to produce myeloid cells with age may be involved in the increase in myeloproliferative 
diseases seen in the elderly (Warren and Rossi, 2008).  Further, HSCs from old mice are 
less efficient at homing to and engrafting in the bone marrow of young irradiated 
recipients (Liang et al., 2005; Morrison et al., 1996).  Additional evidence suggests that 
the proliferative response of murine HSCs to early acting cytokines also declines with 
age (Henckaerts et al., 2004).  Similar results have been observed in human HSCs, in that 
a progressive decline in function as well as HSC number occurs with increasing age 
(Figure 1.3) (Lansdorp et al., 1994). 
 Recent evidence suggests that DNA damage accumulation contributes 
significantly to the decline in stem cell function with age (Nijnik et al., 2007; Rossi et al., 
2007).  Rossi et al. examined hematopoietic stem cell function with age in mice deficient 
in various genomic maintenance pathways, and showed that, although HSC reserves were 
not depleted with age, stem cell functional capacity was severely compromised under 
conditions of stress in old versus young cells.  They hypothesized that the accumulation 
of DNA damage in HSCs during aging may be limiting the function of these cells in 
response to injury.  In accordance with their hypothesis, they showed that 82% LT-HSCs 
from old wild-type mice stained positively for γ- H2AX (an indicator of DNA double-
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stranded breaks), while young LT-HSCs were largely devoid of the damage marker 
(Rossi et al., 2007).   
Epigenetic alterations have also been implicated in HSC aging (Chambers et al., 
2007b; Rossi et al., 2005).  Chambers et al. performed microarray analyses on highly 
purified HSCs from mice aged 2 to 21 months and found a remarkable downregulation of 
genes involved in chromatin remodeling and DNA repair.  Genes involved in 
transcriptional silencing via chromatin remodeling (Smarca4 and Amarcb1) as well as 
histone deacetylases (Hdac1, -5, and -6) and a DNA methyltransferace (Dnmt3b) were 
downregulated in aged cells.  They also showed that several chromosomal regions 
changed with age in a coordinated manner resulting in an overall increase in 
transcriptional activity.  They propose that chromatin dysregulation and epigenetic 
changes drive the loss of cellular function and ultimately drive the aging process in 
HSCs.  Consistent with these data, Polycomb proteins (transcriptional repressors), such as 
Ezh2 and Bmi-1, have been shown to influence self-renewal and cell fate determination 
decisions in HSCs (Lessard et al., 1998; Park et al., 2003).  Ezh2 and Bmi-1 act as 
transcriptional repressors that stabilize the self-renewing HSC population, thus 
downregulation of these genes with age would likely compromise the functional quality 
of the HSC pool.   
Another mechanism contributing to the functional failure of HSCs is cellular 
senescence, a process that results in the irreversible loss of cell division.  Many stimuli 
have been shown to induce the senescence response including, but not limited to, 
telomere erosion, certain types of DNA damage, such as DNA breaks and oxidative 
lesions, epigenetic changes to chromatin organization, as well as exposure to ionizing 
irradiation (Campisi, 2005; Wang et al., 2006). There is increasing evidence that 
senescent cells accumulate with age.  Senescence-associated β-galactosidase, an enzyme 
commonly used as a marker to detect the senescent phenotype, was shown to increase 
with age in various mammalian tissues (Krtolica and Campisi, 2002).  Since stem cells 
are capable of self-renewal and produce progeny to replenish worn-out and damaged cells 
in aged tissues, the induction of stem cell senescence may compromise tissue renewal by 
depletion of stem or progenitor cell pools and thus promote age-related pathologies.    
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  It is apparent that the HSC compartment undergoes considerable age-related 
changes, however it is not yet clear whether theses changes are intrinsic to the cells 
themselves or whether they occur due to alterations in the hematopoietic 
microenvironment, commonly referred to as the HSC niche.  Several studies have shown 
that the systemic milieu regulates stem cell decline during aging.  Liang et al. showed 
that HSCs have a reduced ability to home to the bone marrow and spleen after 
transplantation into old versus young recipients (Liang et al., 2005).  Further experiments 
demonstrated that the muscle stem cell niche adversely effects stem cell function as 
evidenced by the restoration of old stem cell regenerative potential upon exposure to a 
young systemic microenvironment (Conboy et al., 2005; Conboy and Rando, 2005).  It 
has also been reported that the spermatogonial stem cell niche deteriorates with age, 
causing the failure to support an appropriate balance between stem cell self-renewal and 
differentiation and ultimately resulting in age-related infertility in mice (Ryu et al., 
2006).  It is likely that age-related HSC changes derive from intrinsic alterations as well 
as extrinsic alterations of specific subtypes of cells in the HSC niche, thus adding another 
layer of complexity to the stem cell aging process (Figure 1.4).   
 
Genetic Regulation of HSCs 
 
Cell intrinsic aging in B6 and DBA mice 
Inbred strains of laboratory mice provide excellent models to study HSC 
properties, such that strain specific phenotypic differences can be directly attributed to 
underlying genetic differences in the stem cells.  Specifically, the genetic regulation of 
the age-related decline in stem cell function has been demonstrated extensively by 
comparing this divergent phenotype among various mouse strains.  Stem cells in the 
relatively long-lived C57BL/6 (B6) mouse strain, measured by in vitro CAFC and in vivo 
completive repopulation assays, increase in number during aging, whereas stem cells in 
the DBA/2 (D2) strain decease over time and display overt signs of aging (Chen et al., 
1999; de Haan and Van Zant, 1999; Kamminga et al., 2005; Morrison et al., 1996; Yuan 
et al., 2005) (Figure 1.5).  When equal numbers of bone marrow cells from old and young 
B6 mice are mixed with standard competitor cells and injected into lethally irradiated 
 8 
recipients, the old cells have a competitive advantage compared to young cells (Harrison 
et al., 1989; Morrison et al., 1996).  In stark contrast to these results, old stem cell 
populations in the relatively short-lived D2 mice display a significant competitive 
disadvantage compared to young cells (Chen et al., 2000; Harrison et al., 1989; Van Zant 
et al., 1990).  In a series of experiments performed by Van Zant et al. (1990) the strain-
dependent differences in B6 and D2 stem cell aging were elegantly demonstrated.  Eight–
cell embryos from B6 and D2 mice were combined ex vivo to form chimeric embryos that 
were implanted into the uteri of pseudopregnant females (Van Zant et al., 1990).  All 
tissues in the resulting chimeric mice consisted of a mixture of B6 and D2 cells.   During 
aging of the chimeric animals, D2 HSC function progressively declined, evidenced by a 
shift to the B6 genotype in all blood cell lineages by two years of age.  The chimeric mice 
showed complete tolerance to B6 and D2 cells, thus ruling out all possibility that the D2 
genotype is selectively eliminated during aging (Mintz and Silvers, 1967).  Thus the 
chimeras allow for simultaneous assessment of two stem cell populations in a common 
environment, demonstrating cell intrinsic stem cell aging properties in the two genetically 
different mouse strains. It is probably not a coincidence that D2 hematopoiesis in the 
chimeras ceased around the time of the strain’s natural lifespan.  This leaves one to 
postulate that there may be a link between the viability of HSC populations and the 
longevity of organisms.  
In addition to life span and HSC aging phenotypes, B6 and D2 mice show 
significant strain-specific variation in multiple HSC paramaters.  For example, in contrast 
to what we observe in old animals, young D2 mice contain higher numbers of 
hematopoietic stem and progenitor cells when compared to young B6 mice (de Haan and 
Van Zant, 1999; Geiger et al., 2001).  Other HSC strain specific differences include 
higher proliferation or cycling activity in D2 hematopoietic cells (de Haan et al., 1997; 
Van Zant et al., 1983), as well as reduced proliferation in response to early-acting 
cytokines when compared to B6 cells (Henckaerts et al., 2002).   Additional studies have 
shown differences in the percentage of circulating white blood cells, B220+ B cells, as 
well as CD8+ and CD4+ T cells between B6 and D2 mice (Chen et al., 2002).  The 
myriad differences that exist between the hematopoietic systems of B6 and D2 mice 
provides a powerful approach to study the genetic control of HSCs. 
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Forward genetic approach to study stem cell genes 
The completion of the mouse and human genome sequencing projects has greatly 
facilitated our ability to identify and characterize gene function at the level of the whole 
organism.   Specifically, in HSCs, both ‘gene-driven’ (reverse genetics) and ‘phenotype-
driven’ (forward genetics) approaches have been utilized to identify genes and regulatory 
pathways that influence stem cell function.  Reverse genetics approaches rely on the 
ability to manipulate the expression of a specific gene in the whole animal using 
transgenic and knock-out strategies, while forward genetics approaches aim to identify 
genetic polymorphisms that underlie naturally occurring phenotypes (Appleby and 
Ramsdell, 2003).  Due to the numerous differences in HSC properties that exist between 
B6 and D2 mice, forward genetics approaches have been extremely successful in 
identifying quantitative trait loci (QTL) (de Haan et al., 2002; de Haan and Van Zant, 
1999; Geiger et al., 2001; Henckaerts et al., 2002) and genes (Liang et al., 2007) that 
account for strain-specific stem cell properties.  The use of recombinant inbred (RI) 
strains has been vital in our quest to identify QTL and quantitative trait genes (QTG) that 
underlie various HSC traits.   Our lab uses the C57BL/6J cross DBA/2J (BXD) RI strains 
due to the extensive differences between the hematopoietic systems of the B6 and D2 
parental strains from which they were derived.  RI lines are formed by the crossing of B6 
and D2 parental strains, followed by repeated brother-sister mating (Figure 1.6).  During 
inbreeding, homologous recombination reshuffles the two parental genomes in a distinct 
fashion, resulting in alleles that become fixed in a unique pattern (de Haan and Williams, 
2005). The genome of each BXD strain has been mapped in great detail, thus regions of 
B6 and D2 derived DNA can be genotyped, resulting in a strain distribution pattern 
(SDP) for each individual BXD line.  Each BXD strain is then phenotyped for the trait of 
interest to derive a phenotype distribution pattern (PDP).  A computer algorithm is used 
to compare the SDP and PDP and determines the association between a particular trait 
and B6 or D2 alleles at known marker loci.  Significant associations between a trait and a 
genotype define QTLs that contain the gene(s) that control the trait (Wang et al., 2003).  
QTLs can only be mapped if the two parental strains have different alleles at a locus of 
interest, therefore it is necessary to use two strains that show large natural variations in 
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the parameter of interest (Van Zant, 2003).   Once strain specific stem cell phenotypes are 
identified, linkage analysis using BXD RI strains enables the genetic mapping of the 
location of the QTL that contributes to the phenotype in question.   Using this forward 
genetic approach, we and others have been very successful at identifying numerous QTL 
that underlie various HSC traits.  QTL on chromosomes 1, 3, and 5 were found to 
regulate the number of HSCs in young B6 and D2 mice (Geiger et al., 2001), while a 
locus on chromosome 2 was shown to be the major determinant of stem cell number in 
old mice (de Haan and Van Zant, 1999).  Another QTL on chromosome 18 was linked to 
the number of stem cells in both young and old animals (Geiger et al., 2001).  QTL 
governing other strain specific HSC traits such as the response of hematopoietic stem and 
progenitor cells to early acting cytokines (Henckaerts et al., 2002), the fraction of 
hematopoietic progenitor cells killed by the cytotoxic drug hydroxyurea, as well as the 
mobilization efficiency of progenitor cells (Geiger et al., 2004) have also been mapped.  
Interestingly, a QTL that regulates mouse lifespan was mapped to the same location on 
chromosome 2 that regulates the number of HSCs in old mice (de Haan and Van Zant, 
1999; Geiger et al., 2001), suggesting that stem cell pool size may have an effect on 
longevity and that the same gene(s) may regulate the two traits. More recently, genetic 
loci involved in controlling gene expression in HSCs have also been identified using a 
“genetical genomics” approach.  Using this strategy, global gene expression data are 
collected from HSCs isolated from each BXD strain, and mRNA abundance for each 
gene is treated as an individual trait that can be mapped to a particular region of the 
genome (Bystrykh et al., 2005). QTLs that are responsible for variation in expression of 
transcripts can be classified into two groups: cis-acting QTLs which are located at the 
physical position of the transcript itself, and trans-acting QTLs that modulate the 
expression of large numbers of genes throughout the genome. Cis-regulated transcripts 
located in a QTL that controls a particular trait serve as good candidates for quantatittive 
trait gene identification.  
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Quantitation and Identification of HSCs and their Progeny 
 
In vitro cobblestone area forming cell (CAFC) assay 
It has long been established that the HSC compartment represents a hierarchy of 
cells, separated on the basis of pluripotency, differentiation potential, and proliferation 
rate.  The CAFC assay is a convenient in vitro limiting-dilution assay used to predict the 
frequency of different hematopoietic cell subsets in this hierarchy growing as 
“cobblestones” underneath a stromal layer (Ploemacher et al., 1989). A pre-established 
stromal layer, such as one established by FBMD1 cells, allows for the long-term growth 
of stem cells in an in vitro setting.  Primitive stem cells migrate beneath the stromal layer 
and form colonies (cobblestones) at various time-points over a period of a month or 
more.   Cobblestones are defined as a cluster of at least five non-refractive cells growing 
beneath the stromal layer.  The longer the latency for a cobblestone to appear, the more 
primitive in nature the cell.  Thus, cells that form cobblestones on days 7 to 21 
correspond to hematopoietic progenitor cells, while cells that form cobblestones on days 
28 and 35, or later, are considered LT-HSCs.  CAFC frequencies determined at various 
culture times show good correlation with stem cell frequencies determined by more 
expensive and time consuming in vivo assays discussed below (Ploemacher et al., 1992; 
Ploemacher et al., 1991).  The CAFC assay is a fast and relatively easy way to quantify 
stem cells.  However, the cell culture conditions used in the assay do not exactly mimic 
the natural bone marrow microenvironemnt (which has been shown to be very hypoxic) 
and the assay is not capable of measuring the in vivo homing ability of stem cells.  
Therefore, the gold standard for measuring HSC activity remains in vivo repopulation 
experiments.    
 
In vivo competitive repopulation assays  
As mentioned previously, HSCs have two distinct properties; 1) the ability to self-
regenerate into cells that are functionally identical to the stem cell from which were 
derived and 2) they are pluripotent and have the ability to differentiate into all of the eight 
major lineages of lymphoid, myeloid and erythroid cells.  These hallmark HSC properties 
are measured empirically by their potential to regenerate and sustain the 
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lymphohematopoietic compartment upon transplantation into lethally irradiated 
secondary hosts.   The first in vivo assay for stem cells was introduced by Till and 
McCulloch (Till and McCulloch, 1961), in which they noticed that cells obtained from 
the bone marrow or spleen of donor mice formed macroscopic colonies in the spleens of 
lethally irradiated recipient mice.  These spleen-colony forming units (CFU-S) could be 
enumerated, therefore enabling the frequency of CFU-S in the initial cell inoculation to 
be quantitated.  Although it was later determined that CFU-S were not able to sustain 
long-term hematopoiesis (Jones et al., 1990), this was the first ground-breaking assay for 
the functional identification and quantification of HSCs in vivo.  
 The first assay to measure the true multilineage reconstitution potential of HSCs 
in vivo was introduced by Harrison in 1980 (Harrison, 1980).  This competitive 
repopulation assay measures the functional potential of an unknown source of HSCs (test 
cells) relative to a known number of distinguishable “competitor” cells.  When equal 
numbers of test and competitor cells are co-injected into lethally irradiated mice, 
theoretically 50% of the hematopoietic cells in the recipient will be regenerated by each 
population.  However, any deviation from the 50% regeneration by one of the donors 
indicates either a competitive advantage or disadvantage.  Although this assay provides 
information about the repopulating ability of HSCs compared to competitor cells, it 
cannot distinguish between increased/decreased proliferation of individual HSCs and an 
actual increase/decrease in absolute HSC numbers.  To address this problem the standard 
competitive repopulation assay was modified to introduce a limiting dilution design, in 
which graded doses of donor test cells are injected into lethally irradiated, but genetically 
distinguishable, recipient mice along with a set number of competitor cells to ensure 
survival of the recipient even when the test cell sample contains little or no repopulating 
activity (Szilvassy et al., 1990).  The number of mice negative for reconstitution in each 
cell dose is then measured several months later, and the frequency of HSCs (defined as 
competitive repopulating units, CRU) is calculated using Poisson statistics and the 
method of maximum likelihood (Szilvassy et al., 1990; Szilvassy et al., 1989).   
 Both the standard competitive repopulation assay and the CRU assay take 
advantage of the Ly5 congenic B6 mouse strains whose white blood cells can be 
distinguished by their expression of the a (Ly5.1) or b (Ly5.2) forms of the ptprc 
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alloantigen. Typically, wild-type B6 mice expressing the Ly5.2 allele are used as donors 
and B6.SJL(Boy J)  mice expressing the Ly5.1 allele are used for competitor cells and 
recipients.  Test cell (donor) contribution to myeloid and lymphoid cells in the recipient 
is then quantitated by flow cytometric analysis of cells stained with fluorescently labeled 
Ly5.1 and Ly5.2 antibodies.  
 
Flow cytometric identification of HSCs 
Great advances in flow cytometry over the past several years have allowed the 
isolation of highly purified primitive stem cell populations.  Using fluorescently labeled 
antibodies directed against specific cell surface receptors, it is possible to identify, 
quantify, and sort various hematopoietic cell subsets to near purity.  Although several 
approaches have been developed, staining for the presence or absence of cell surface 
markers is the most commonly used strategy to separate different hematopoietic 
populations.   The general consensus is that primitive stem cells are characterized by the 
absence of lineage antigens expressed on differentiated cells such as granulocytes, 
macrophages, B and T lymphocytes, and erythrocytes.  Further enrichment of HSCs 
relies on the presence of Sca-1, a membrane glycoprotein, and c-kit, a tyrosine kinase 
receptor (Ogawa et al., 1991; Spangrude et al., 1988).  The Lineage- Sca-1+ c-Kit+ 
(LSK) cells comprise ~0.1% of the whole bone marrow and are considered to be highly 
enriched for HSCs.  
In the last few years, a new cell surface phenotype based on the presence and 
absence of SLAM proteins, has been used to purify a population of which ~50% of single 
cells reconstituted lethally irradiated animals (Kiel et al., 2005).  SLAM proteins are a 
group of 10-11 cell surface receptors that regulate the proliferation and activation of 
lymphocytes (Howie et al., 2002; Wang et al., 2004).  Primitive HSCs are highly 
enriched within the CD150+ CD48- cells population.  Further, SLAM proteins are 
expressed by many mouse strains and appear to be conserved among HSCs from old, 
mobilized, and transplanted cells (Yilmaz et al., 2006), thus ensuring the purity of HSCs 
when examining cells across a variety of contexts. 
Another widely used HSC purification strategy relies on the robust ability of 
HSCs to efflux a variety of compounds (Goodell et al., 1996).  Efflux of the fluorescent 
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DNA binding dye Hoechst 33342 results in a “side population” (SP) of cells that is 
enriched for HSCs.  SP cells were shown to be enriched ~1000 fold for HSC activity, and 
provided long-tern mulitlineage contribution in lethally irradiated recipients (Goodell et 
al., 1996).  Inclusion of the canonical LSK cell surface markers in combination with the 
Hoechst 33342 efflux property allows for even further enrichment for HSCs, yielding a 
population termed SParKLS (LSK cells in the SP) (Lin and Goodell, 2006). 
 
Mapping of a QTL Linked to the Change in HSC Number in Old B6 and DBA Mice 
The strain specific HSC aging phenotype between B6 and D2 mice is the focus of 
this dissertation.  As mentioned previously, when using the CAFC assay to measure HSC 
frequency, our lab found that the stem cell population in long-lived B6 mice increases 
steadily with age, whereas the frequency of HSCs in the relatively short-lived D2 strain 
follows a bell shaped curve throughout life, reaching a peak at ~1 year then declining in 
old age (Figure 1.5) (de Haan and Van Zant, 1999).  In order to understand the genetic 
basis for the variation of HSC numbers in old B6 and D2 mice, we used the 
aforementioned forward genetic approach and performed genetic linkage analysis in 
BXD RI strains of mice.  Using this approach, we identified a locus on murine 
chromosome 2 that is significantly linked to the variation in frequency of HSCs in aged 
B6 and D2 animals. The locus on chromosome 2 was linked to the number of HSCs only 
in old animals, thus qualifying as a true “aging locus” at which the B6 allele is 
responsible for the expansion of HSCs in old B6 animals (de Haan and Van Zant, 1999). 
In order to definitively associate stem cell aging with the QTL identified on chromosome 
2, our lab created congenic mice in which the distal region of chromosome 2 containing 
the QTL was transferred from D2 mice onto a B6 background.  The introgressed D2 
genomic interval was derived from BXD strain 31 because it phenotypically best 
demonstrated the decline in HSCs in old age.  Using a speed congenic approach, BXD31 
mice were backcrossed to the B6 parental strain to expunge D2 DNA located outside of 
the QTL region (Wakeland et al., 1997).  The generation of mice using a speed congenic 
approach relies on genotyping each generation for the distribution of allelic markers 
every 10 cM along the entire mouse genome. Mice with the greatest amount of parental 
DNA and bearing donor alleles at the QTL are then chosen for further backcrossing.  The 
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resulting chromosome 2 congenic mice have a genome that is ~99% B6 with the 
exception of the introgressed D2 congenic interval spanning 50 Mbp on the end of 
chromosome 2.  Congenic mouse models are very powerful tools when studying QTLs, 
as they allow for the confirmation that a particular chromosomal locus does influence a 
particular trait.  Essentially one can determine if in fact “the phenotype follows the 
genotype.”  We next hypothesized that congenic B.D Ch2 mice (hereafter referred to 
simply as congenics), in which the QTL interval in B6 mice has been replaced by D2 
alleles, would confer the D2 phenotype of decreased HSCs numbers only in aged mice.  
To test our hypothesis, CAFC d35 frequency was measured in young and old B6 
background and congenic mice.  At 2 months of age, the frequency of HSCs in congenic 
bone marrow did not differ significantly from the frequency HSCs in B6 animals. In 
contrast, at 24 months of age, the frequency of HSCs in congenic bone marrow was a 
statistically significant 2-fold less than in age-matched B6 mice (Figure 1.7A). Because 
bone marrow cellularity showed only a modest 20% increase in old animals, the 
decreased frequency of HSCs in old congenic mice represents a decrease in the absolute 
number of HSCs in their bone marrow (Geiger et al., 2005). 
Because stringent testing of stem cell activity and frequency is best accomplished 
by in vivo transplantation experiments, an additional competitive repopulation experiment 
was performed in which equal numbers of congenic or B6 bone marrow cells were mixed 
with an equal number of competitor cells and injected into lethally irradiated mice.  In 
contrast to almost equal contribution to PB at early time points, the contribution of 
congenic cells to peripheral blood chimerism eleven months post transplant was 
significantly less than contribution from B6 cells (Figure 1.7B).  Thus, in vitro and in 
vivo results confirmed the linkage analysis, and demonstrated that the influence exerted 
by the D2 allele caused a significant reduction in HSC frequency and activity with age 
(Geiger et al., 2005). 
Aging phenotypes in mice are difficult to study, partly because test subjects must 
age ~2 years before they can be used in an experiment.  In order to overcome this hurdle, 
as well as to determine if DNA integrity influenced stem cell aging, we administered 
either 1 or 2 Gy of gamma radiation to congenic and B6 animals, a treatment we 
hypothesized would cause DNA damage and partial depletion of the stem cell pool, thus 
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creating a prematurely aged the stem cell population (Figure 1.8A).  Two weeks post 
irradiation, we injected the test cells (B6 or congenic) along with an equal number of 
competitor cells into lethally irradiated mice.  As expected, bone marrow cells from mice 
given no radiation contributed equally to peripheral blood (PB) chimerism in recipient 
animals up to 20 weeks post transplant.  Bone marrow from congenic mice given 1 Gy, 
which results in ~20-30 chromosomal breaks per genome, displayed an initial defect in 
contribution to PB chimerism, but by 20 weeks post transplant showed an equivalent 
contribution to PB as did B6 cells.  In contrast, BM from congenic animals receiving 2 
Gy contributed only 10% of PB cells at 8 weeks following transplant, and this low 
contribution remained unchanged for the duration of the experiment, a finding consistent 
with stem cell exhaustion due to radiation (Figure 1.8B) (Geiger et al., 2005).  Thus, 
although low dose irradiation does not precisely mimic the natural aging process, it does 
elicit a phenotypic response in young congenic mice that can be measured in a relatively 
short period of time and confirms the notion that DNA damage in stem cells leads to stem 
cell aging.    
 
Experimental Goals and Significance 
The experimental goal of the work performed in this dissertation was to identify 
specific gene(s) and molecular pathways underlying HSC aging in two commonly used 
strains of inbred mice using a forward genetic approach.  Three specific aims are 
proposed to accomplish this goal: 1) to confirm the phenotype of the congenic mouse 
model in highly purified CD150+CD48- stem cells and to study the mechanistic basis for 
the difference in HSC numbers in old mice by looking at self-renewal, cell cycle, and 
apoptosis in B6 and congenic mice using a previously established irradiation study to 
mimic the natural aging process; 2) to perform microarray analyses using stem and 
progenitor enriched hematopoietic cells from B6 and congenic mice in order to identify 
genes that are differentially expressed between the strains that may contribute to the 
different HSC aging phenotypes; and 3) to overexpress candidate gene(s) identified in the 
microarray analysis in primary hematopoietic cells and perform functional studies in 
order to determine whether their overexpression results in quantitative changes in HSC 
number. 
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Human HSCs undergo similar age-related changes as do the mouse, thus it is 
probable that some of the genes and regulatory mechanisms uncovered with our murine 
model will be applicable to human HSC biology.  Therefore these studies are important 
because they may lead to the identification the genes that regulate and control the number 
of HSCs in aged humans as well as mice.  Further, these studies may identify genes that 
serve as biomarkers to distinguish an individual’s ability to serve as  “good” or “bad” 
bone marrow transplant donors. In view of the importance of stem cells for maintaining 
immune function and in a broader sense tissue homeostasis and longevity, there is a 
critical need to better understand the mechanisms involved in HSC aging.    
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Figure 1.1 The HSC hierarchy.   
The HSC compartment can be functionally divided into three populations; long-term 
HSCs, which have extensive self-renewal capacity, short-term HSCs, which have limited 
self-renewal capacity, and multipotent progenitor cells which cannot self-renew and give 
rise to common lymphoid progenitors (CLP) and common myeloid progenitors (CMP).  
CLPs differentiate into pro-B, T, and natural killer (NK) cells, which then give rise to 
mature B and T cells and NK cells.  CMPs differentiate into granulocyte/macrophage 
progenitors (GMP) and mekaryocyte/erythroid progenitors (GEP).  GMPs then give rise 
to mature macrophages and granulocytes. GEPs differentiate into megakaryocyte 
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progenitors (MkP) and erythroid progenitors (ErP), which give rise to platelets and 
erythroblasts, respectively.  Both GMPs and CLPs can give rise to mouse dendritic cells.   
Reprinted by permission from Macmillan Publishers Ltd: [Nature] Reya, T, Morrison, SJ, 
Clarke MF, Weissman IL. 2001. Stem cells, cancer and cancer stem cells. Nature 
414:105-111, copyright (2001). 
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Figure 1.2 Epigenetic changes that accompany aging and tumorigenesis.  
Normal young stem cells undergo controlled self-renewal divisions and differentiate to 
produce large numbers of high-quality mature cells. These well-orchestrated processes 
rely heavily upon regulated epigenetic modifications of gene expression. However, as 
stem cells age, their functional attributes decline. They have a reduced capacity for self-
renewal and differentiate to give rise to fewer, low-quality daughter cells. A general loss 
of repression, resulting in dysregulation of gene expression and decreased chromatin 
stability, also accompany the aging process. It is hypothesized that, in addition to 
alterations in gene expression and reduced chromatin stability, the aging 
microenvironment creates conditions permissive to cancer development. Subsequent 
cancer-promoting epigenetic events, including silencing of tumor suppressor genes and 
activation of oncogenes promote the transition from a normal to a cancerous state. The 
cancer stem cell has extensive self-renewal capacity and differentiates to give rise to self-
renewing (disease sustaining) as well as terminally differentiated progeny. It is important 
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to note, however, that the cancer stem cell does not necessarily have to arise from aged 
stem cell populations, but instead can arise from young stem cells whose normal 
developmental processes have gone awry.  Reprinted by permission from Macmillan 
Publishers Ltd: [Leukemia] Oakley, E.J., and Van Zant, G. 2007. Unraveling the complex 
regulation of stem cells: implications for aging and cancer. Leukemia 21:612-621, 
copyright (2007). 
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Figure 1.3 Decline in human HSCs with advancing age. 
Human HSCs, defined as CD34+ cells, show a steady decline in number as individuals 
age. 
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Figure 1.4 Stem cell theory of aging.   
Schematic representing the stem cell theory of aging as it pertains to the hematopoietic 
system.  Aging results in the accumulation of damage in the HSC compartment, which in 
turn leads to compromised function of this system and ultimately reduced health of the 
entire organism. Adapted from Waterstrat, A., E. J. Oakley, A. Miller, and G. Van Zant.  
Stem cells and aging. Modified from Telomeres and Telomerase in Aging, Disease, and 
Cancer.  L. Rudolph, ed.  Springer, Berlin, 2007. 
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Figure 1.5 Frequency of CAFC day35 cells in young and old B6 and D2 mice.   
The frequency of CAFC day35 cells in B6 mice increases in a linear fashion with age, 
whereas the frequency of CAFC day35 cells in the D2 strain follows a bell shaped curve 
throughout life, with HSC numbers reaching a peak at ~1 year then declining in old age. 
Modified from de Haan, G., and Van Zant, G. 1999. Dynamic changes in mouse 
hematopoietic stem cell numbers during aging. Blood 93:3294-3301. 
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Figure 1.6 Illustration of the derivation of BXD RI strains of mice. 
C57BL/6J cross DBA/2J (BXD) RI strains are created by the crossing of B6 and D2 
parental strains, followed by repeated brother-sister mating of their progeny for 20 
generations.  The alleles in each RI line become fixed in a unique fashion, thus each 
strain becomes a mosaic of the two parental genomes.  Phenotypes are correlated with B6 
or D2 alleles present at specific markers located throughout the mouse genome.  This 
linkage analysis has enabled the genetic mapping of numerous QTL that influence 
various HSC phenotypes. 
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Figure 1.7 In vitro and in vivo confirmation of the chromosome 2 QTL. 
Decreased frequency of LSK cells, as measured by the CAFC assay, in old congenic mice 
compared with the frequency in old B6 mice (P < 0.05) (A).  Bone marrow from two 
animals for each strain was analyzed in six CAFC assays per animal.  Equal numbers of 
competitor and either B6 or congenic bone marrow cells were co-injected into lethally 
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irradiated recipient mice, and the animals were aged 10 months.  Chimerism in the 
peripheral blood of the recipients was determined at various time points after 
transplantation.  Congenic stem cells displayed a significant competitive disadvantage in 
aged animals compared to cells in B6 mice (P < 0.05) (B).   From Geiger, H., Rennebeck, 
G., and Van Zant, G. 2005. Regulation of hematopoietic stem cell aging in vivo by a 
distinct genetic element. Proc Natl Acad Sci U S A 102:5102-5107. Copyright (2005) 
National Academy of Sciences, U.S.A. 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 28 
 
 
 
 
 
 
 
Figure 1.8 Irradiation scheme to mimic HSC aging. 
Diagram of the competitive repopulation assay used for these analyses (A).  B6 and 
congenic mice were given 0, 1 or 2 Gy of irradiation, and after a resting period of two 
weeks, bone marrow cells were harvested and transplanted in equal numbers into lethally 
irradiated recipient mice.  Chimerism in the peripheral blood of the recipients was 
determined at various time points after transplantation (B).  n = 4 mice for each dose. 
Adapted from Geiger, H., Rennebeck, G., and Van Zant, G. 2005. Regulation of 
hematopoietic stem cell aging in vivo by a distinct genetic element. Proc Natl Acad Sci U 
S A 102:5102-5107. Copyright (2005) National Academy of Sciences, U.S.A. 
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CHAPTER TWO 
 
Analysis of self-renewal, cell cycling, and apoptosis in hematopoietic stem and 
progenitor cells in congenic and background mice using the surrogate aging assay 
 
Summary 
 
It has previously been established that a quantitative trait locus (QTL) on murine 
chromosome 2 regulates the change in the number of hematopoietic stem cells (HSCs) in 
old C57/B6 (B6) and DBA2 (D2) mice.  Congenic mice were created by introgressing D2 
alleles onto a B6 background, and in vitro and in vivo studies confirmed that these mice 
display the D2 phenotype of reduced HSC number and function in old age.   Further, a 
surrogate assay for the HSC aging phenotype was established in which low-dose 
radiation was administered to young mice to simulate the stress of aging on the HSC 
population.  Young congenic HSCs were found to be extremely sensitive to 2 Gy of 
irradiation compared to young B6 HSCs.  However, the underlying mechanisms that 
account for differences in HSC number in old B6 and congenic mice as well as the 
differential radiation sensitivities are not yet known.  Therefore in these studies, I 
investigated the cell cycle, apoptotic, and self-renewal capacity of B6 and congenic HSCs 
subject to 2 Gy of irradiation using various flow cytometry and serial bone marrow 
transplantation techniques.  I used the surrogate assay to mimic aging with hopes of 
identifying common mechanisms that may be differentially regulated in aged B6 and 
congenic mice.  Additionally, I further confirmed the phenotype of the congenic mouse 
model and showed that old congenic mice have 39% fewer CD150+ CD48- than do old 
B6 mice.  I did not detect any significant differences in the percentage of cells in S phase 
in whole bone marrow, lineage negative (Lin-), or Lin- Sca-1+ c-kit+ (LSK) cells 
between B6 and congenic mice subject to 2 Gy of irradiation.  However, when analyzing 
the apoptotic status of these cell populations after 2 Gy of irradiation, I demonstrate that 
B6 Lin- cells undergo significantly more apoptosis (34.7%) than do similarly treated 
congenic Lin- cells (12.4%).  Under steady-state conditions (no irradiation), I observed 
no difference in the percentage of whole bone marrow, Lin- and LSK cells undergoing 
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apoptosis between B6 and congenic mice.   Finally, serial transplantation experiments 
revealed a dramatic repopulation advantage in B6 mice treated with 2 Gy of irradiation 
compared to similarly treated congenic mice in all recipient groups, thus indicating that 
the D2 alleles in the chromosme 2 QTL confer lower self-renewal capacity of HSCs 
exposed to 2 Gy of irradiation.  In sum these results indicate that the chromosome 2 QTL 
affects the apoptotic and self-renewal capacity of artificially aged hematopoietic stem and 
progenitor cells, which may account for the variation in HSC number in old B6 and D2 
mice.   
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Introduction 
 
 Hematopoietic stem cells must balance self-renewal, differentiation, and cell 
death decisions in order to sustain hematopoiesis throughout the lifetime of an organism 
as well as be poised for extensive proliferation upon demand.  The normal fate decisions 
of stem cells can easily be summarized:  a) a stem cell may remain quiescent and not 
divide at all; b) a stem cell may undergo symmetric cell divisions to generate two new 
self-renewing stem cells or two new differentiated progeny; c) a stem cell may undergo 
asymmetric cell divisions and give rise to one new stem cell and one differentiated cell; 
and finally d) a stem cell may undergo apoptosis and no longer contribute to 
hematopoiesis (Figure 2.1).  There is strong evidence that cell intrinsic factors tightly 
regulate the survival, differentiation, and proliferation of stem cells, and thus ultimately 
influence the functional quality and size of the hematopoietic compartment throughout 
the lifetime of an organism.   
 The small number of HSCs in an adult mouse must replace approximately 2.4 x 
108 red bloods cells and 4 x 106 non-lymphoid peripheral blood cells each day (Cheshier 
et al., 1999) as well as be ready to proliferate in response to hematological stresses.  
According to the clonal-succession hypothesis which was first proposed in 1965, HSCs 
meet the great demands of hematopoiesis by allowing only one or a few HSC clones to 
give rise to mature blood cells at any one time (Kay, 1965).  According to this model, 
other HSCs in the pool remain quiescent and do not contribute to hematopoiesis until the 
proliferative capacity of the active HSC is exhausted.  However, Pietrzyk and Bradford 
later challenged this theory when they analyzed in vivo bromodeoxyuridine (BrdU) 
incorporation rates of day 14 CFU-S and Hoechst low (Holo), Rhodanmine123 low (Rholo) 
enriched HSCs, respectively (Bradford et al., 1997; Pietrzyk et al., 1985). Pietrzyk et al. 
showed that 75% of progenitors capable of forming day-14 CFU-S had incorporated 
BrdU over a period of one month (Pietrzyk et al., 1985) and Bradford et al. demonstrated 
that 89% of HoloRholo cells incorporated BrdU over a period of 12 weeks (Bradford et 
al., 1997).  Cheshier et al. went on to show that 99% of HSCs incorporated BrdU by the 
end of six months, thus clearly demonstrating that all HSC do in fact cycle on a regular 
basis (Cheshier et al., 1999).    This high proliferative capacity of HSCs allows for 
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emergency responses, but under steady state conditions, must be tightly regulated in order 
to maintain hematopoietic homeostasis.   
Perhaps one of the most important factors in sustaining hematopoietic 
homeostasis and preventing exhaustion of the stem cell pool throughout the lifespan of an 
organism is maintaining appropriate cell cycle control.  Cyclin dependent kinase 
inhibitors (CKIs) halt cell cycle progression and have been shown to play an important 
role in stem cell regulation (Cheng et al., 2000; Walkley et al., 2005; Yuan et al., 2004).  
p21cip1/waf1 (p21), a G1 checkpoint regulator highly expressed in the quiescent fraction of 
bone marrow cells, has been shown to restrict HSC cycling and thus maintain stem cell 
quiescence and survival.  p21-deficiency increases HSC proliferation and amplifies and  
the size of the HSC pool under homeostatic conditions in the mouse (Cheng et al., 2000).  
The proportion of quiescent cells in G0 phase of the cell cycle is reduced in p21-/- mice, 
and in agreement with these findings, p21-/- mice are more sensitive to 5-flurouracil, a cell 
cycle specific toxin that kills cycling cells, than wild-type controls.  Further, the 
hematopoietic potential of p21 deficient HSCs was nearly exhausted after two rounds of 
serial bone marrow transplantation (Cheng et al., 2000).  Together these results indicate 
p21 as a key regulator of stem cell cycling that functions to prevent stem cell exhaustion 
under prolonged stress (Ezoe et al., 2004). 
 Unlike p21, p27KIP1 (p27) is a CKI whose expression is observed in more mature 
progenitors cells.   The number, cell cycling, and self-renewal of HSCs were found to be 
normal in p27 deficient mice, however the mice displayed an increase in the number and 
proliferative capacity of progenitor cells (Cheng et al., 2000).  Progenitor cells from p27 
null mice were able to expand and regenerate after serial transplantation, thus indicating 
p27 as an important modulator of the repopulation efficiency but not overall pool size of 
HSC cells (Cheng et al., 2000).  In contrast to p21 studies, yet similar to p27 findings, 
HSCs deficient in p18INK4C (p18), a member of the INK4 family of CKIs, display 
diminished cell exhaustion compared to wild-type cells after serial transplantation over 
three years (Yu et al., 2006).  Interestingly, deletion of p18 was able to counteract the 
accelerated exhaustion of HSC repopulation resulting from p21 deficiency.   The 
advantage imparted to p18 deficient cells is thought to be due to increased self-renewal of 
the transplanted HSCs in vivo rather than increased donor cell proliferation (Yuan et al., 
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2004).  These studies demonstrate the importance of CKIs in regulating HSC cell cycle 
kinetics and also indicate the highly divergent effects that cell cycle inhibitors can have 
on stem cell function.   
 Unlike p21, p27 and p18, which have not been directly linked to stem cell aging, 
the stem cell intrinsic effects of p16INK4a have been linked to age-dependent changes in 
stem cell function. In B6 HSCs, p16 INK4a mRNA expression was shown to increase with 
age.  Thus, in order to determine the functional role of this protein, Janzen et al. 
examined the hematopoietic system of mice deficient in p16INK4a (Janzen et al., 2006).  
They found that, in contrast to young animals in which no differences were found, the 
frequency of old HSCs was increased in p16INK4a-/- animals compared to wild-type.  They 
also showed that old p16INK4a-/- HSCs had increased self-renewal capacity when 
compared to wild-type cells in serial transplantation assays, thus suggesting that the 
absence of p16 INK4a improved HSC function under conditions of stress.  They propose 
that inhibition of p16INK4a may prevent some of the age-related changes that occur in old 
stem cells.  
Several studies suggest that, in addition to cell cycle regulators, apoptosis plays an 
important role in homeostasis of stem cell numbers both under steady state conditions as 
well as during the aging process. For example, increased numbers of HSCs were found in 
the bone marrow of transgenetic mice overexpresssing BCL-2 (an anti-apoptotic protein) 
in all hematopoietic tissues (Domen et al., 2000).  BCL-2 overexpression has also been 
shown to protect HSCs from radiation- and growth factor deprivation-induced cell death 
(Domen et al., 2000; Domen et al., 1998).  Further, HSCs overexpressing BCL-2 
displayed a competitive repopulation advantage in transplantation assay, thus clearly 
establishing apoptosis as an important mechanism in regulating HSC numbers in vivo 
(Domen, 2001; Domen et al., 2000).  
Apoptotic pathways have also been implicated in regulating HSC dynamics in 
aged stem cell populations.  Cellular aging is associated with the accumulation of DNA 
damage and genomic instability, thus it has been hypothesized that proteins that regulate 
DNA damage response pathways are key regulators of aging (Dumble et al., 2007).  p53 
is a tumor suppressor protein that is activated in response to numerous cellular stresses, 
including DNA damage and oncogenic activation, to induce cell cycle arrest and/or 
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eventual apoptosis.  Mice expressing a hyperactive p53 protein display a heightened 
tumor resistance, and surprisingly significantly reduced longevity compared to wild-type 
mice (Tyner et al., 2002).  The mutant mice showed generalized organ atrophy and 
reduced tolerance to stress beginning in middle age that become more apparent in old 
age.  Relevant to this discussion, aged p53 mutant mice also displayed a reduced ability 
to generate white blood cells after ablation of hematopoietic progenitors with 5-
flurouracil.  It was hypothesized that reduced HSC function drove the decrease in 
regenerative capacity.   Indeed, subsequent experiments showed that B6 mice expressing 
hyperactive p53 (p53+/m) failed to exhibit age-associated increases in stem cell number 
(consistent with wild-type B6 mice), and in fact showed a reduced number of HSCs 
compared to age-matched p53+/+ and p53+/- mice.  In addition, HSC proliferation was 
found to be inversely correlated with p53 activity, with p53+/- mice retaining the highest 
level of proliferative capacity at old age (Dumble et al., 2007).  Although the mechanism 
by which p53 reduces HSC proliferation and functionality is not yet known, a clear role 
for the pro-apoptotic p53 protein has been established in the HSC aging process.  A 
scenario is favored in which altered p53 dosage affects the self-renewal capacity of 
HSCs, which overtime results in functional differences in the hematopoietic 
compartments of mutant and wild-type animals (Dumble et al., 2007).   
Perhaps the most important regulators of HSCs are those that govern self-renewal 
decisions. Self-renewal is crucial for stem cell function because it is required for stem 
cells to persist throughout the lifetime of the animal.  Numerous cell intrinsic 
transcription factors, transcriptional repressors, and signaling molecules have been 
indicated as important regulators of stem cell self-renewal and maintenance.  For 
example, homeobox (Hox) genes, which encode transcription factors that regulate 
segment identity in the developing embryo, have been identified and implicated in the 
regulation of various stages of hematopoiesis (Abramovich and Humphries, 2005; 
Abramovich et al., 2005; Lawrence et al., 1996; Lewis, 1978).  In particular, HoxB4 has 
been considered an important regulator of primitive HSCs because it is expressed highly 
in human CD34+ cells but is rapidly down-regulated upon differentiation (Sauvageau et 
al., 1994). Overexpression of HoxB4 in the bone marrow compartment was shown to 
increase HSC numbers, thus suggesting it acts as a positive regulator of HSC self-renewal 
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(Antonchuk et al., 2002; Krosl et al., 2003; Miyake et al., 2006; Sauvageau et al., 1995).  
Because maintanence of the HSC compartment is governed by a balance between growth 
promoting signals as well as signals that promote senescence and apoptosis, one group 
sought to determine the combined effects of HoxB4 overexpression and p21 down-
regulation (Miyake et al., 2006).  As mentioned previously, p21 acts to maintain HSCs in 
a quiescent state, therefore it was hypothesized that p21 deficiency would enhance the 
HoxB4-mediated increase in self-renewal capacity.  Indeed it was found that the 
simultaneous modulation of p21 and HoxB4 generated a ten- fold increase in the number 
of repopulating HSCs after 5 days of ex vivo culture (Miyake et al., 2006).  Another 
transcription factor, Growth factor independence 1 (Gfi1), controls HSC self-renewal by 
restricting their proliferation potential (Hock et al., 2004; Zeng et al., 2004).  Gfi1 
deficiency was shown to increase HSC proliferation and decrease repopulation efficiency 
during serial transplantation.  In fact, Gfi1 is thought to be an upstream regulator of p21, 
whose expression is decreased in Gfi1 null cells.  Factors that govern HSC self-renewal 
and cellular fate decisions must be tightly controlled both to prevent premature 
exhaustion and to maintain the integrity of the HSC population.  
Clearly, HSC population kinetics are governed by highly orchestrated processes 
that must remain balanced throughout the lifespan of an organism.  The fact that all HSCs 
are regularly cycling means that the fate of this cell population has to be determined 
continuously.  The regulation of HSC numbers has to be strictly controlled not only to 
prevent unwanted expansion, but also to prevent premature contraction or aging of this 
important cell population.  Therefore, in order to address the potential mechanisms that 
contribute to the cell-intrinsic differences in HSC number in old B6 and D2 mice, I 
investigated the self-renewal, cell cycle, and apoptotic status of young B6 and congenic 
mice that were given 2 Gy of irradiation.  I used a previously established surrogate aging 
assay, involving low dose irradiation, with hopes of identifying common mechanisms 
that may be differentially regulated in aged B6 and congenic mice. 
Before performing the mechanistic studies I first sought to determine whether the 
congenic stem cell aging defect was observed in a CD150+ CD48- cell population. 
Recently, it has been shown that HSCs can be highly enriched using a simple 
combination of antibodies directed against the SLAM family member proteins CD150 
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and CD48 (Kiel et al., 2005; Kim et al., 2006; Yilmaz et al., 2006).  CD150+ CD48- 
bone marrow cell populations contain 21% long-term multi-lineage reconstituting cells 
when intravenously injected into lethally irradiated mice (similar to results obtained with 
LSK cells) and it has been shown that SLAM family receptor expression is conserved 
among young and old HSCs (Kiel et al., 2005; Yilmaz et al., 2006).  Our lab has 
previously shown that D2 alleles in the chromosome 2 QTL confer a decrease in CAFC 
day 35 cells in old age, as well as an in vivo competitive disadvantage when compared to 
B6 alleles (Geiger et al., 2005).   To further confirm the phenotype of the congenic 
mouse model and to ensure that I am studying functionally similar cells in young and old 
mice, I measured the number of CD150+ CD48- cells in the bone marrow of these mice 
relative to that of B6.  
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Materials and Methods 
Animals 
Young (2-4 months) and old (24-25 months) C57BL/6 (B6) (Ptprcb [CD 45.2]) 
mice were purchased from the National Institute of Aging (NIA) Aged Mouse Colony at 
Harlan Sprague Dawley (Indianapolis, IN).   Chromosome 2 congenic mice, with a 
genetic interval from D2 mice spanning 50 Mbp  (130Mbp -180 Mbp) on the distal end of 
chromosome 2, were generated as described previously (Geiger et al., 2005).  Young (2-4 
months) and aged (24-27 months) congenic animals were used in the experiments.  
B6.SJL (Ptprca [CD 45.1] were purchased from the Jackson Laboratories and were used 
as adoptive recipients in serial transplantation assays.  All mice were female and were 
housed in the Division of Laboratory Animal Resources (DLAR) at the University of 
Kentucky Chandler Medical Center and were maintained under pathogen-free conditions 
according to NIH guidelines for animal welfare.  
 
Immunofluorescent staining of cells and flow cytometry 
Mice were euthanized by CO2 asphyxiation and the femora and tibiae were 
removed to a Petri dish containing Hanks Balanced Salt Solution (HBSS, GIBCO) 
supplemented with 2% fetal bovine serum (FBS, Invitrogen).  Femora and tibiae were 
flushed with 4 mL media to obtain a single cell suspension.  Mononucleated cells were 
obtained via Ficoll gradient separation and Fc receptors were subsequently blocked with 
anti-CD16/32 (clone 2.4G2, Fc Block) to prevent non-specific staining.  For Lineage 
negative (Lin-) isolation, cells were identified by the lack of cell surface antigens 
characteristic of cells committed to individual lineages of blood cell development.  The 
lineage cocktail consisted of the following antibodies: CD5 (clone 53-7.3) and CD8a 
(clone 53-6.7) to identify T cells, CD45R/B220 (clone RA3-6B2) to identify B cells, 
CD11b/Mac-1 (clone M1/70) and Ly-6G/Gr-1 (clone RB6-8C5) to identify macrophages, 
and Ter119/Ly-76 (clone Ter-119) to identify erythrocytes.  All antibodies were 
biotinylated, and immunofluorescent staining was achieved with streptavidin-fluorescein 
isothiocyanate (SA-FITC).  Light density bone marrow cells were stained with the above 
lineage cocktail as well as stem cell specific cell surface markers, phycoerythrin (PE)-
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conjugated Ly-6A/E (Sca-1; cloneE13-161.7) and allophycocyanin (APC)-conjugated 
CD117 (c-kit; clone ne2B8) to identify a population enriched in stem cells (Lin-, Sca-1+, 
c-kit+ cells or LSK cells).  In order to isolate rare CD150+ CD48- cells, whole bone 
marrow was centrifuged over a Ficoll gradient to enrich for mononucleated cells, and the 
recovered low-density cells were then labeled with antibodies directed against the SLAM 
receptors.  CD150+ CD48- cells were identified by staining with PE-conjugated anti-
mouse CD150 (clone TC15-12F12.2) and FITC-conjugated hampster antimouse CD48 
(BCM).  In order to determine the number of CD150+ CD48- cells per 2 femora and 2 
tibiae, cell counts were performed following Ficoll gradient centrifugation on a 
hemocytometer.  Cell counts were then divided by the number of mice used in the 
experiment and then multiplied by the percent total CD150+ CD48- cells as determined 
by flow cytometry staining, thus yielding the total number of CD150+ CD48- cells per 2 
femora and 2 tibiae.  For each cell preparation, dead cells were excluded by propidium 
iodide (PI) staining.  All monoclonal antibodies were purchased from BD Pharmingen.  
Cells were analyzed and sorted on a triple-laser FacsVantage  (Becton-Dickinson) flow 
cytometer. 
 
Cell Cycle Analyses 
Cell cycle analyses were carried out in young B6 and congenic mice using the in 
vivo BrdU incorporation assay (Dolbeare et al., 1990).  BrdU is a thymidine analog that is 
incorporated into newly synthesized DNA by cells entering and progressing through the S 
phase of the cell cycle.  BrdU can be stained with anti-BrdU fluorescent antibodies in 
cells to determine the frequency of cells in a population that are synthesizing DNA.   
Mice were injected intraperitoneally with BrdU (1 mg per kg of body weight) at various 
time points (0h, 6h, 16h, 3d, 7d) following 2 Gy of gamma irradiation (whole body) 
delivered from a 137Cs source Mark 1 Irradiator (J.L. Shepherd and Associates) at a dose 
rate of 1.73 Gy per minute.  One-hour post injection the mice were sacrificed and their 
bone marrow LSK cells were enumerated as described above. Analysis of BrdU 
incorporation in whole bone marrow, Lin-, and LSK cells was performed using a BrdU 
Flow Kit (BD Pharmingen) according to the manufacturer’s directions.  Cells in S phase 
were identified as having a DNA content intermediate between diploid and tetraploid and 
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staining positive for BrdU.  Flow cytometric analysis was performed on a FACSVantage 
(Becton-Dickinson).  For a given time point, we performed a 3 way ANOVA with strain, 
cell cycle phase (GO/G1, S, G2/M), and cell population (WBM, Lin-, LSK) as factors.  
We then determined if there were significant inter-strain differences for a particular time 
and cell cycle phase.  
Apoptotic analysis of cells 
Apoptosis is characterized by a variety of morphological features such as 
blebbing of plasma and nuclear membranes, aggregation of nuclear chromatin, and 
disruption of cytoskeletal architecture (Israels and Israels, 1999).  In the early stages of 
apoptosis, phosphatidylserine (PS), a membrane phospholipid, is translocated from the 
inner to the outer leaflet of the plasma membrane, thereby exposing PS to the external 
cellular environment (Martin et al., 1995).  Annexin V is a Ca2+ dependent phopholipid 
binding protein that has high affinity for PS, and is useful for identifying apoptotic cells 
with exposed PS (Vermes et al., 1995).  Annexin V conjugated to FITC will be used as a 
probe for flow cytometric analysis of cells undergoing apoptosis.        
Young B6 and congenic mice were given 0 or 2 Gy of gamma radiation (whole 
body) from a 137Cs source Mark 1 Irradiator (J.L. Shepherd and Associates) at a dose rate 
of 1.73  Gy per minute 2 hours prior to sacrifice. Bone marrow cells were isolated and 
stained with LSK antibodies as described.  Additional staining with FITC-conjugated 
Annexin V (BD Pharmingen) and 7-AAD (BD Pharmingen) enabled the identification of 
apoptotic cells.  Cells that stain positive for Annexin V and negative for 7-AAD are 
undergoing apoptosis (Vermes et al., 1995).  Three independent experiments were 
performed using each strain for each treatment (0 versus 2 Gy radiation), with at least two 
mice for each experiment.  Flow cytometric analysis was performed on a triple laser 
FACSVantage flow cytometer (Becton-Dickinson).  
 
Serial Transplantation Assay to Measure HSC Self-Renewal 
Young B6 and congenic mice were irradiated with 0, 1, or 2 Gy of gamma 
radiation (whole body) from a 137Cs source Mark 1 Irradiator (J.L. Shepherd and 
Associates) at a dose rate of 1.73 Gy per minute three days prior to sacrifice.  Whole 
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bone marrow cells were isolated from young B6 and congenic mice as described above.  
These cells (CD45.2) served as “test” cells for individual transplantation assays.  Equal 
numbers (1x106) of test cells were admixed with CD45.1 competitor cells and injected 
into lethally irradiated (9 Gy) CD45.1 primary recipients.  Marrow was harvested from 
the primary recipients 20 weeks post transplant and injected into secondary recipients.  
An identical regimen was repeated once more.  At each transplant, peripheral blood, 
whole bone marrow, Lin-, and LSK cells were analyzed.  For peripheral blood anaylsis, 
mice were bled from the retroorbital sinus under isofluorane anesthesia prior to 
sacrificing by CO2 asphyxiation.  Erythrocytes were depleted by hypotonic lysis and 
leukocytes were stained with FITC-conjugated monoclonal anti-CD45.2 (clone ALI4A2) 
and PE-conjugated monoclonal antibodies (Pharmingen) specific for B (anti-
CD45R/B220; clone RA36B2) and T lymphocytes (anti-Thy1.2; clone 30H12) or 
granulocytes (anti-Ly6G/Gr-1; clone RB6-8C5) and macrophages (anti-CD11b/Mac-1; 
clone M1/70).  Cells were analyzed using a FACScan flow cytometer (Becton-
Dickinson).  Bone marrow Lin- and LSK cells were stained and analyzed as described 
above. The self-renewal capacity was determined by comparing the percentage of B6 and 
congenic derived CD45.2+ cells in recipients at each round of transplantation.   
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Results 
 
CD150+ CD48- Cells in Congenic Mice 
In order to ensure that the HSC aging phenotype is observed in functionally equivalent 
cell populations, we measured the number of CD150+ CD48- cells in the bone marrow of 
young and old B6 and congenic mice.  As expected, at a young age, I found no significant 
difference (P > 0.05) in the number of CD150+ CD48- cells per 2 femora and 2 tibiae 
between B6 and congenic mice (38 x 103 ± 8 x 103 cells per mouse and 23 x 103 ± 9 x 103 
cells per mouse, respectively).  However, in old mice, replacement of the B6 alleles at the 
QTL with D2 alleles in the congenic interval caused a significant decrease in the absolute 
number of CD150+ CD48- cells per 2 femora and 2 tibiae.  Old B6 mice contained 103 x 
103 (± 14 x 103) CD150+ CD48- cells per 2 femora and 2 tibiae whereas old congenic 
mice contained 59 x 103  (± 8 x 103) CD150+ CD48- cells per 2 femora and 2 tibiae, a 
43% decrease  (P ≤ 0.05) (Figure 2.2A).  Moreover, on the basis of frequency, light 
density marrow from old B6 mice contained 0.25% ± (0.03%) CD150+ CD48- cells, 39% 
more than that for old congenic mice (0.18% (±0.01%) (P ≤ 0.01) (Figure 2.2B). The fact 
that the absolute number of CD150+ CD48- cells increased in old congenic mice 
compared to young probably reflects the fact that regulation of stem cell aging is a 
complex quantitative trait that is controlled by multiple loci, in addition to the 
chromosome 2 QTL, and that body size increases ~50% from 2 months to 2 years.  
Therefore old congenic mice display an intermediate phenotype when compared to old 
B6 and D2 mice.  
 
Cell Cycle Analyses 
Cell cycling has the ability to influence HSC numbers in two ways; 1) increases 
or decreases in the number of actively cycling cells can either increase or decrease the 
total number of HSCs, and 2) increases or decreases in the time it takes to proceed 
through the cell cycle can subsequently increase or decrease HSC numbers.  However, 
even though increased stem cell cycling has the potential to increase HSC numbers, 
exhaustion of HSC self-renewal potential, resulting in terminal differentiation or 
senescence, is an inevitable outcome of a large number of cellular divisions.  Additional 
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studies suggest that engraftment efficiency may be correlated with different phases of the 
cell cycle.  Decreased engraftment potential was observed when HSCs were progressing 
through S/G2/M phases of the cell cycle, thus suggesting that active cycling negatively 
correlates with engraftment potential (Bowie et al., 2006; Dykstra and de Haan, 2008; 
Fleming et al., 1993; Habibian et al., 1998; Vermes et al., 1995).  Having previously 
shown that congenic mice are severely compromised after 2 Gy of irradiation in a 
transplant setting, I hypothesized that there would be an increase in the number of 
congenic HSCs in S phase following irradiation, and that this increase in cycling would 
cause replicative exhaustion of their stem cell pool, and perhaps explain why they cannot 
sustain hematopoiesis in a competitive transplant setting.  Increased cell cycling after a 
stressor such as irradiaton, may also be indicative of the cells inability to activate 
appropriate cell cycle checkpoints.  This hypothesis can also be extended to old congenic 
mice, in that increased cell cycling in old HSCs (or throughout the lifespan of the 
organism) would lead to exhaustion of the stem cell pool as well as decrease engraftment 
potential in a competitive transplant setting.  In order to address the role of the 
chromosome 2 QTL in HSC cell cycle kinetics, I measured the proportion of HSCs in S 
phase of the cell cycle using the BrdU incorporation assay (Dolbeare et al., 1990).  
Young B6 and congenic mice were given 2 Gy of irradiation and the percent of cells in S 
phase in whole bone marrow, Lin-, and LSK cells were measured at 0h, 6h, 16h, 3d, and 
7d following irradiation (Figure 2.3A).  I found no significant difference in the 
percentage of cells in S phase in whole bone marrow, Lin- and LSK cells between young 
B6 and congenic mice under steady-state conditions (no irradiation), as well as at all time 
points tested following 2 Gy of irradiation (Figure 2.3B).  Congenic cells, like B6 cells 
were able to respond appropriately to stress by increasing cell proliferation in all cell 
populations.  Approximately 4-5% of LSK cells (in both strains) stained positive for 
BrdU 1 hour following in vivo intraperitoneal injection (Figure 2.4A).  As expected, 
almost 90% of LSK cells were in G0/G1 phase of the cell cycle under steady-state 
conditions, indicated by the lack of BrdU staining as well as by having a diploid content 
of DNA (Figure 2.4B).  Six hours following irradiation, I observed a slight but non-
significant decrease in the percent of B6 LSK cells in S phase compared to an increase in 
congenic LSK cells (Figure 2.4A).  Sixteen hours post irradiation the percent of LSK 
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cells in S phase in both strains increased, with a concurrent decrease in the percent of 
LSK cells in G0/G1 phase, again demonstrating that the congenic LSK cells do not have 
a proliferation defect  (Figure 2.4A and B).  As with B6 cells, congenic LSK cells 
remained in a high state of proliferation at least one week following irradiation, while the 
percent of cells in G0/G1 remained low in comparison to steady state levels.  This inverse 
relationship in the percent of LSK cells in S phase and percent of cells in G0/G1 
illustrates how the poised LSK cells are activated to enter the cell cycle after stress in 
order to replace the differentiated cells that were eliminated.   Interestingly, six hours post 
irradiation we observed a large, but non-significant, increase in the percent of B6 cells in 
G2/M phase of the cell cycle compared to congenic cells (Figure 2.4C).  This increase 
was transient, as by sixteen hours post irradiation the percent of B6 cells in G2/M 
returned to almost steady-state levels.  Three days post irradiation treatment, we saw no 
significant difference in the percent of LSK cells in G2/M between B6 and congenic 
mice.  However, seven days after treatment, the percent of LSK cells in G2/M in 
congenic mice returned to steady-state levels, whereas the percent of LSK cells in G2/M 
in B6 mice remained elevated compared to pre-treatment levels (Figure 2.4C). 
 
Apoptosis Analyses 
Numerous studies have shown that apoptosis plays an important role in maintaining HSC 
homeostasis (Janzen et al., 2006; Opferman et al., 2005; Rodrigues et al., 2005), yet few 
have addressed the involvement of apoptosis in the aged hematopoietic system.  As stem 
cells age, they accumulate increasing amounts of macromolecular and DNA damage 
likely due to the replicative stress that occurs over the long lifespan of the cell.   
Damaged cells in the aged HSC compartment undergo apoptosis in order to rid the pool 
of dysfunctional cells that would then give rise to damaged progeny or would perhaps 
become tumorigenic.  The same ensues when the cells are exposed to stressors, such as 
low-dose radiation or chemotherapeutic drugs.  Thus, we addressed the question of 
whether or not congenic HSCs undergo higher levels of apoptosis compared to B6 HSCs, 
perhaps contributing to the decreased number of stem cells as the mice age.  To 
determine whether D2 alleles in the QTL influence the apoptotic response in irradiated 
congenic animals, we assessed annexin V staining of whole bone marrow, Lin-, and LSK 
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cells (Figure 2.5A).  Young (2-4 months) B6 and congenic mice were given 0 or 2 Gy of 
irradiation and after two hours the mice were sacrificed and their bone marrow cells were 
analyzed for apoptosis.  We found no significant differences in annexin V staining in 
whole bone marrow, Lin-, and LSK cells between B6 (3.9%  ± 2.4%, 4.5% ± 1.0%, 4.14 
± 2.1%, respectively) and congenic (2.9% ± 3.1%, 2.9% ± 2.0%, 2.1% ± 2.2%, 
respectively) mice under steady-state conditions (no radiation) (Figure 2.5B).  Similarly, 
we found no significant variation in annexin V staining in whole bone marrow and LSK 
cells from B6 (8.7% ± 4.1% and 8.2% ± 6.6%, respectively) and congenic (4.0% ± 2.4% 
and 13.9% ± 5.0%, respectively) mice 2 hours post 2 Gy of irradiation.  However, in the 
Lin- cell population, we observed a significant (~ 3 fold) increase (P = 0.01) in annexin V 
staining in B6 (34.7% ± 3.2%) mice post irradiation treatment compared to congenic 
(12.4% ± 8.6%) animals.  We also observed increases in Annexin V staining in all cell 
populations tested except congenic whole bone marrow cells post 2 Gy of irradiation.   
 
Self Renewal Analyses  
A signature feature of stem cells is their ability to undergo self-renewing 
divisions, an attribute that is best tested by the serial transplantation of bone marrow cells 
through a series of lethally irradiated recipients.  We therefore tested the self-renewal 
capacity of congenic HSCs in serial transplantation experiments in order to determine 
whether the difference in HSC numbers in old congenic and B6 mice was due to 
decreased self-renewal capacity of the congenic cells. One or 2 Gy of irradiation was 
administered to young (2 months) B6 and congenic mice, which we hypothesized would 
cause significant replicative stress, thus creating an “aged” stem cell population.  We 
chose to irradiate cells with 1 Gy in addition to 2 in hopes of identifying an intermediate 
phenotype.  After 3 days, the mice were sacrificed and their bone marrow cells were 
harvested and transplanted into lethally (9.0 Gy) irradiated CD45.1 recipients along with 
and equal number of CD45.1 competitor cells (Figure 2.6).  Twenty weeks post 
transplant, the primary recipients were sacrificed and their bone marrow cells were 
harvested and injected into lethally irradiated secondary recipients without the addition of 
competitor cells, and such serial transplantation was continued once more.  At each 
transplant, the peripheral blood and bone marrow of the primary, secondary, and tertiary 
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recipients were analyzed by staining the cells with antibodies directed against CD45.1, 
CD45.2, c-kit, sca-1, as well as the Lin- cocktail described above, therefore allowing us 
to examine the percentage of donor derived cells (CD45.2) in the stem (LSK) and 
progenitor (Lin-) compartments.  Greater self-renewal capacity of HSCs from one strain 
relative to the other is reflected by the percentage of donor derived cells (either B6 or 
congeic).  In primary, secondary, and tertiary recipients, we saw no significant difference 
in the percentage of CD45.2+ cells between B6 and congenic mice given no irradiation in 
peripheral blood as well as in the bone marrow nucleated cells (Figure 2.7).  In contrast, 
in recipient mice injected with cells receiving 2 Gy of irradiation, we observed 
significantly less CD45.2+ congenic cells in primary recipient bone marrow cells and in 
secondary and tertiary recipient peripheral blood and bone marrow cells (Figure 2.7).  
Further, contribution to mature peripheral blood cell lineages (macrophages/granulocytes, 
B cells, and T cells) from congenic mice subject to 2 Gy of irradiation was compromised 
compared to similarly treated B6 mice in all three recipient groups (Figure 2.8).  Thus, 
serial transplantation of bone marrow cells demonstrates that 2 Gy of irradiation imparts 
a stress that severely compromises the self-renewal capacity of congenic cells compared 
to B6 cells, and that this decline in cellular function is intrinsic to the stem cells. 
Surprisingly, in recipient mice injected with cells receiving 1 Gy of irradiation, I 
observed significantly more CD45.2+ congenic cells in secondary recipient peripheral 
blood and bone marrow compared to CD45.2+ B6 cells (Figure 2.7).  Similarly, I also 
observed higher contribution to all mature peripheral blood cell lineages in secondary 
recipients that received cells from congenic mice irradiated with 1 Gy compared to 
recipients that received cells from B6 mice irradiated with 1 Gy (Figure 2.8).   However, 
despite contributing ~50% to overall CD45.2 chimerism, the percentage of LSK cells 
derived from congenic mice treated with 1 Gy of irradiation was significantly lower in 
secondary recipients compared to LSK cells derived from similarly treated B6 mice.  This 
indicates that LSK cells derived from congenic mice treated with 1 Gy of irradiation may 
differentiate rather than self-renew after the irradiation insult, which is reflected in the 
large number of differentiated cells but lack of LSK cells in secondary and tertiary 
recipient mice.  
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Discussion 
 
HSCs from young congenic mice display no apparent hematopoietic defects 
compared to HSCs from young B6 mice, whereas old congenic stem cells display overt 
signs of aging.  However, using a surrogate aging assay, we found that we could uncover 
hematopoietic defects in young congenic mice simply by treating them with irradiation, 
which causes significant DNA damage in the stem cell pool.  However, it remains to be 
determined why old and irradiated congenic HSCs are functionally compromised 
compared to age matched or similarly treated B6 HSCs.  I therefore measured the 
proliferative, apoptotic, and self-renewal capabilities of young congenic mice treated with 
2 Gy of irradiation.  The unavailability of large numbers of old congenic mice prevented 
the same analyses from being carried out in these animals.  Although low dose irradiation 
does not precisely mimic the aging process, it does elicit a measurable phenotypic 
response in the congenic mice, which we hypothesize will be recapitulated in old mice as 
well.   
I first showed that while there is no difference in the number of CD150+ CD48- 
cells between young B6 and congenic mice, old congenic mice have significantly fewer 
CD150+ CD48- cells compared to old B6 mice.  This finding is important for two 
reasons; (1) it demonstrates that the difference in stem cell number in aged mice can be 
extended to highly purified primitive stem cell populations, and (2) it excludes the 
possibility of measuring the frequency of contaminating, non-HSCs in old mice, and 
ensures that we are analyzing the phenotype in functionally similar cells populations.  
The fact that I did not detect variation in the frequency of young stem cells demonstrates 
that D2 alleles at other loci are responsible for this variation.  It is not practical to obtain 
enough CD150+ CD48- cells for use in mechanistic studies due to the fact they make up 
such a small percentage of the total bone marrow population. Therefore in my studies I 
rely on the absence of lineage markers and the presence of Sca-1 and c-kit (LSK cells) to 
denote a population enriched in primitive HSCs.  CD150+ CD48- cells and LSK cells 
display similar levels of long-term multilineage reconstitution potential, therefore I feel 
that the use of LSK cells represents the best possible cell population in which to study 
HSC properties.      
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In order to measure the proportion of HSCs in S phase of the cell cycle at various 
time points following 2 Gy of irradiation, I performed in vivo BrdU labeling studies. 
Consistent with published data, approximately 4-5% of LSK cells stained positive for 
BrdU 1 hour following in vivo intraperitoneal injection, and no significant differences 
were observed between B6 and congenic mice under steady-state conditions (no 
irradiation) (Cheshier et al., 1999; Morrison et al., 1995).  As expected almost 90% of 
LSK cells were in G0/G1 phase of the cell cycle under steady-state conditions, indicated 
by the lack of BrdU staining as well as by having a diploid content of DNA. Although all 
HSCs cycle regularly, this method only measures the fraction of HSCs replicating their 
DNA during a one hour pulse of BrdU, which explains why only a small fraction of 
HSCs were found to be in S phase.  Nonetheless, this finding is consistent with the idea 
that a small number of HSCs are always dividing in order to maintain steady-state 
hematopoiesis.   
I chose to look at the fraction of cells in S phase at various time points following 
irradiation in order to determine how hematopoietic cells from B6 and congenic mice 
respond (in terms of cell cycle kinetics) to stress.  At all time points following irradiation, 
I observed no significant difference in the percentage of WBM, Lin-, and LSK cells in S 
phase between the two mouse strains, thus presumably excluding the possibility that 
congenic and B6 hematopoietic cells exhibit differences in cell cycle kinetics following 
irradiation.  In contrast to WBM and Lin- cell populations, the percentage of LSK cells in 
S phase in both strains remain elevated by 2- to 3- fold at least 7 days following 
irradiation.  Although no significant differences between the percentage of HSCs in S 
phase were observed, a higher percentage of congenic LSK cells stained positive for 
BrdU compared to B6 cells prior to and at all time points following irradiation. This 
slightly higher cycling activity could potentially result in earlier exhaustion of the 
congenic HSC pool and contribute to the decreased competitiveness seen in 
transplantation assays.  Moreover, the subtle increase in congenic LSK cycling may be 
indicative of their inability to activate cell cycle checkpoints in response to cellular 
stressors.  In this scenario, congenic LSK cells may accumulate DNA damage, which 
over time could lead to functional defects in their stem cell population.  If cell cycle 
checkpoint control were compromised throughout the lifespan of an organism, the stem 
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cell pool would eventually become cluttered with damaged cells, ultimately resulting in 
an overall decline in function in this cell population with age.  
  Next, I analyzed the percentage of cells undergoing apoptosis in the bone 
marrow compartment of B6 and congenic mice exposed to irradiation. Presumably, 
increased levels of apoptosis in congenic LSK cells could contribute to the decreased 
numbers of stem cells observed in old mice as well as contribute to the irradiation 
sensitivity phenotype of congenic LSK cells if they undergo apoptosis after irradiation 
exposure.  Surprisingly, I was unable to detect any profound differences in percentages of 
WBM and LSK cells undergoing apoptosis between B6 and congenic mice.  In both 
strains, we found that a higher percentage of Lin- cells were undergoing apoptosis 
compared to LSK cells. This finding is in agreement with other studies, which suggest 
that progenitor cell populations are more prone to apoptosis compared to more quiescent 
stem cells (Niedernhofer, 2008; Park and Gerson, 2005; Reya et al., 2001).  However, I 
found that B6 Lin- cells undergo significantly more apoptosis than do congenic Lin- cells 
after 2 Gy of irradiation.  This finding was unexpected, as I hypothesized that increased 
apoptosis would correlate with decreased HSC functionality.  However, the higher 
percentage of B6 Lin- cells undergoing apoptosis compared to congenic Lin- cells 
following irradiation may have several causes.  First, the higher percentage of apoptosis 
in the B6 Lin- population supports the idea that B6 cells have a heightened DNA damage 
response compared to congenic cells. Following cellular damage, B6 progenitor cells 
may be able to activate checkpoint responses more efficiently than congenic cells, thus 
enabling them to either repair DNA damage or undergo apoptosis.   This in turn would 
protect the B6 hematopoietic compartment from giving rise to cells with damaged DNA, 
and thus ultimately protect the long-term function of this cell population.  This scenario is 
consistent with our cell cycle data: congenic cells continue to cycle even when exposed to 
DNA damaging events instead of activating cell cycle checkpoints or undergoing 
apoptosis. Inappropriate activation of cell cycle checkpoints and/or induction of apoptosis 
in response to stress would cause the congenic HSC pool to accumulate damaged cells.  
These damaged cells may eventually undergo growth arrest and/or become senescent, and 
thus ultimately contribute to the decreased function the congenic hematopoietic system in 
aged mice. Indeed, several recent papers indicate that DNA damage accumulation in 
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HSCs results in a decline in their cellular function (Niedernhofer, 2008; Nijnik et al., 
2007; Rossi et al., 2007).  I hypothesize that altered cell cycle checkpoint control, 
resulting in improper cell cycle exit and induction of apoptosis, leads to extensive DNA 
damage accumulation in congenic Lin- and LSK cells, and thus likely contributes to age 
associated hematopoietic defects. 
 Another contributing factor to increased B6 Lin- apoptosis after irradiation is the 
increased transcript expression of BCL2-like 11, as was later revealed by our microarray 
analyses.  BCL2-like 11, also referred to as Bim, is a BH3-only protein member of the 
Bcl-2 family of proteins (O'Connor et al., 1998).  Bim acts as an apoptosis facilitator and 
has been shown to play an important role in the apoptosis of early hematopoietic 
progenitors (Kuribara et al., 2004). 
Hematopoietic homeostasis relies on the presence of a functional HSC pool which 
is maintained throughout the life time of an animal by self renewing stem cell divisions.  
Given that the primary role of adult stem cells is to replenish aged and functionally 
impaired tissues, this self-renewal capacity must be maintained during the aging process 
in order to ensure maximal longevity.  In order to determine the effects of the 
chromosome 2 QTL on HSC self-renewal, I performed serial transplantation experiments, 
which serve as the most stringent test of HSC potential.   I hypothesized that congenic 
mice exposed to 2 Gy of irradiation (and by extension aged mice as well) would display a 
stem cell self-renewal defect compared to B6 mice.  Defects in self-renewal ability would 
provide a mechanistic basis as to why the number of congenic HSCs declines during 
normal aging.   
As expected, under steady state conditions (no irradiation), I saw no significant 
difference in the percentage of CD45.2+ cells from B6 and congenic mice in peripheral 
blood and bone marrow nucleated cells in all three groups of recipients (Figure 2.7).  
However, when analyzing the hematopoietic compartment of recipients that received 
cells irradiated with 2 Gy, I found significantly fewer congenic CD45.2+ cells in the bone 
marrow of primary, secondary, and tertiary recipients as well as in the peripheral blood of 
secondary and tertiary recipients 20 weeks post-transplant compared to B6 CD45.2+ 
cells.  Having determined that there is no dramatic difference in the proliferation rate of 
B6 and congenic HSCs, I next determined whether or not there was a difference in the 
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number of B6 or congenic derived LSK cells in the recipient mice, thus leading to the 
competitive repopulation differences that we observed with each serial transplant.  
Indeed, results from analyzing the bone marrow of recipient mice revealed that 
significantly fewer LSK cells were derived from congenic cells treated with 2 Gy of 
irradiation compared to B6 cells in secondary and tertiary recipients.  Thus, the 
competitive disadvantage of the congenic cells treated with 2 Gy of irradiation results 
from a lower stem cell frequency in recipient mice.  Virtually no LSK cells derived from 
congenic cells treated with 2 Gy of irradiation were observed in secondary and tertiary 
recipient mice, indicating that the replicative stress imparted after the first transplant 
resulted in stem cell exhaustion.   I hypothesize that the same scenario would ensue in 
aged congenic LSK cells, in that they would have a severe self-renewal defect when 
compared to old B6 LSK cells.  Indeed, a decreased congenic self-renewal capacity may 
explain the decrease in stem cell number in these mice during normal aging.   
The fact that congenic cells treated with 1 Gy of irradiation contributed 
significantly more to secondary recipient peripheral blood and bone marrow nucleated 
cells than did similarly treated B6 cells was not expected.  However, it may suggest that 
B6 differentiated cells are sensitive to irradiation up to some threshold approaching 2 Gy, 
after which they may activate DNA damage response and repair pathways.  Indeed, I 
observed that B6 Lin- cells undergo significantly more apoptosis after 2 Gy of irradiation 
compared to congenic cells.  Apoptosis may be the mechanism by which they purge their 
hematopoietic compartment, thus preserving the self-renewal capacity and ensuring 
maintenance of a high quality HSC pool over time.  It may also suggest that congenic 
LSK cells chose to differentiate rather than self-renew after 1 Gy of irradiation. This 
scenario would explain why we observed high contribution to overall CD45.2 chimerism 
and mature blood cells, but a very low percentage of LSK cells in all recipient groups 
injected with congenic cells.   After 2 Gy of irradiation the congenics have already 
exhausted their LSK pool, thus explaining why I observed virtually no LSK cells as well 
as differentiated cells in secondary and tertiary recipients.  The B6 cells, on the other 
hand preserve their may LSK pool after 1 Gy at the expense of producing differentiated 
cells.  By the time that they are hit with 2 Gy of irradiation they have enough LSK cells 
to both maintain the pool as well as differentiate into mature blood cells.   Therefore, at 
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least in B6 and our congenic mice, it is vital to preserve a primitive stem cell pool when 
faced with cellular stressors, at the expense of differentiated cells, in order to survive the 
insult.  Additionally, the fact that the B6 cells treated with 1 Gy of irradiation 
reconstituted tertiary recipients as well as congenic cells, suggests that the preservation of 
their LSK pool in secondary recipients was sufficient to rescue their hematopoietic defect 
observed in secondary recipients.  It is possible however that the LSK cells under these 
conditions (irradiation as well as serial transplant) have lost fidelity of the markers used 
to identify them. In this scenario, the LSK cells present in B6 mice after 1 Gy may not be 
functionally similar to LSK cells under normal conditions.  This may explain why both 
B6 and congenic cells were able to contribute equally to peripheral blood chimerism in 
tertiary recipients, even though 1 Gy of irradiation apparently eradicated the congenic 
LSK cells in secondary recipients.    
In sum, I demonstrated that D2 alleles in the chromosome 2 QTL reduce the 
number of CD150+ CD48- cells in old mice compared to B6 alleles.  In addition, D2 
alleles in the QTL blunt the ability to purge damaged Lin- cells after exposure to 2 Gy of 
irradiation as well as abolish the repopulating capacity, and hence self-renewal, of 
congenic cells exposed to 2 Gy of irradiation.  I hypothesize that old cells would perform 
similar to irradiated cells in cell cycle, apoptosis, and self-renewal assays, and am 
currently testing this hypothesis using aged congenic mice.  
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Figure 2.1 Cellular fate decisions of stem cells.   
There are four possible cell fate decisions for stem cells: 1) a stem cell may remain 
quiescent and not divide at all; 2) a stem cell may undergo symmetric cell divisions to 
generate two new self-renewing stem cells or two new differentiated progeny; 3) a stem 
cell may undergo asymmetric cell divisions and give rise to one new stem cell and one 
differentiated cell; and 4) a stem cell may undergo apoptosis and no longer contribute to 
hematopoiesis. SC = stem cell, P = progenitor cell. 
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Figure 2.2 The number of CD150+ CD48- cells per 2 femora and 2 tibiae in 
young and old B6 and congenic mice as determined by flow cytometry.  At a 
young age, there is no significant difference in the number of CD150+ CD48- cells 
between B6 and congenic mice.  As the mice age, B6 mice accumulate significantly 
more CD150+ CD48- cells per 2 femora and 2 tibiae than do congenic mice (A). 
Results are given as mean ± SEM (n ≥ 5 mice, three replicate experiments).  
Representative dot plots of bone marrow cells showing the percentage of CD150+ 
CD48- cells in old congenic and B6 mice (B). Old congenic mice have significantly 
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less CD150+ CD48- cells compared to old B6 mice.   On average B6 mice have a 
higher percentage of CD150+ CD48- cells (0.25% ± 0.03%) compared to old 
congenic mice (0.18% ± 0.01%) (P ≤ 0.01).  The plots represent one experiment 
where 3-4 mice were pooled. † indicates statistical significance for comparison of old 
B6 and congenic cells (P ≤ 0.05).  * indicates statistical significance for intra-strain 
comparison of cells as a function of age (P ≤ 0.05).  Results are given as mean ± 
SEM. 
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Figure 2.3 Analysis of cell cycling in three hematopoietic cell populations following 
irradiation treatment.  Schematic representing the time scheme used for irradiation 
treatment (A).  Irradiation was administered to B6 and congenic mice 6 hrs, 16 hrs, 3 
days, and 7 days prior to sacrifice.  One hour before the mice were sacrificed, 150 mg per 
kg of body weight of 5-flurouracil was intraperitoneally injected into the mice.  I 
observed no significant difference in the percentage of cells in S-phase (BrdU+) between 
B6 and congenic WBM, Lin-, and LSK cells at all time points tested following irradiation 
treatment (P > 0.05) (B).  Three replicate experiments were performed using 3-5 mice per 
strain for experiments. The pooled results are given as mean ± SEM.  
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Figure 2.4 Profiles of the percent of LSK cells in various phases of the cell cycle 
following irradiation treatment.  Percent of LSK cells in S phase of the cell cycle prior 
to (0 hr) and at several time points following irradiation (A).  Approximately 4-5% of 
LSK cells (in both strains) were in S phase under steady-state conditions, however this 
percentage increased at various timepoints following irradiation.  A higher percentage of 
congenic LSK cells stained positive for BrdU at all time points tested.  Approximately 
90% of LSK cells were in G0/G1 phase of the cell cycle under steady-state conditions, 
however this percentage decreased in both strains following irradiation (B). Six hours 
post irradiation we observed a large, but non-significant, increase in the percent of B6 
cells in G2/M phase of the cell cycle compared to congenic cells (C).  This increase was 
transient, as by sixteen hours post irradiation the percent of B6 cells in G2/M returned to 
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C 
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almost steady-state levels.  Seven days after treatment, the percent of LSK cells in G2/M 
in B6 mice remained elevated compared to the percent of LSK cells in G2/M in congenic 
mice (C).   
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Figure 2.5 Identification of Annexin V positive/7AAD negative apoptotic HSCs.  
Cells were stained with a lineage cocktail and a gate was set to identify Lin- cells.  
Further gates were set to detect sca-1+ and c-kit+ cells.  The resulting Lin- sca-1+ c-kit+ 
(LSK) cells were then analyzed for Annexin V and 7AAD staining.   Flow cytometry 
plots are from one representative animal (A).  No differences in the percentage of 
apoptoic cells between B6 and congenic mice exist under steady state conditions (B).   A 
significant increase in apoptosis was observed in the B6 Lin- population post 2 Gy of 
irradiation compared to congenics (B). † indicates statistical significance for comparison 
of B6 Lin- cells before and after irradiation (P  ≤ 0.01).   * indicates statistical 
significance for comparison of B6 and congenic Lin- cells after irradiation (P = 0.01). 
Results are given as mean ± SEM (n ≥ 2 mice, three replicate experiments).  
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Figure 2.6 Self-renewal analysis of B6 and congenic HSCs pre- and post irradiation 
treatment.  B6 and chromosome 2 congenic mice were subject to 0, 1 or 2 Gy of 
irradiation and after 3 days bone marrow was harvested and injected in lethally irradiated 
primary recipients. After 20 weeks, primary recipients were sacrificed and harvested 
bone marrow was injected to secondary recipients.  This regimen was repeated once 
more.  At each transplant, the peripheral blood and bone marrow of the primary, 
secondary, and tertiary recipients were analyzed. n = 4-5 mice for each recipient group. 
 
 
 
 
 
 
 
 
 
  (unirradiated) 
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Figure 2.7 Self-renewal analysis of HSC in serial bone marrow transplantation. 
B6 and congenic derived peripheral blood leukocytes and bone marrow nucleated 
cells treated with various doses of irradiation were analyzed 20 weeks after they 
were transplanted into primary, secondary, tertiary recipients. Each data point 
represents the mean for groups of mice (P ≤ 0.05).  
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Figure 2.8 B6 and congenic contribution to mature blood cell lineages during serial 
transplantation.  B6 and congenic derived B cells, T cells, and 
macrophage/granulocyte cells treated with various doses of irradiation were 
analyzed 20 weeks after they were transplanted into primary, secondary, tertiary 
recipients. Each data point represents the mean for groups of mice (P ≤ 0.05).  
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CHAPTER THREE 
 
Microarray analysis and identification of candidate quantitative trait genes that 
regulate the HSC aging phenotype 
 
Summary 
 
In order to identify the candidate gene(s) located within the chromosome 2 QTL 
that regulate the differential HSC aging and/or the differential radiation sensitivity 
phenotypes of B6 and congenic mice, microarray gene chip studies were performed.  I 
measured the expression profiles of young and old B6 and congenic lineage- (Lin-) cells 
prior to and post treatment with 2 Gy of total body radiation using Affymetrix M430 
microarray chips. Stringent statistical anaylses revealed that a total of 90 genes located 
within the chromosome 2 QTL were differentially expressed between the B6 and 
congenic mice.  Next, using the WebQTL database, I found that 6 of the 90 differentially 
expressed genes located within the QTL were cis-regulated and therefore served as the 
best possible candidate genes for regulating the HSC traits.  Of the 6 cis-regulated genes, 
I chose to confirm the differential expression of Retinoblastoma like protein 1 (p107) and 
Sorting nexin 5 (Snx5) due to their previous involvement in hematopoiesis and/or stem 
cell biology.  Real time PCR in stem (LSK) and progenitor (Lin-) cell populations 
validated the differential expression of both genes.  Snx5 mRNA was found to be 
elevated in young and old Lin- and LSK cells and p107 mRNA was found to be elevated 
in young and old Lin- cells and in old LSK cells.  These results demonstrate that B6 
alleles in the chromosome 2 QTL up-regulate the expression of both Snx5 and p107 and 
suggest that these genes are positive regulators of HSC number and therefore may 
regulate the HSC aging and/or radiation sensitivity phenotypes.   
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Introduction 
 
Stem cells are indispensable entities in most multicellular organisms in that they 
are responsible for forming tissues during early development and maintaining them in the 
adult.  This property places stem cells at the forefront of both developmental biology and 
regenerative medicine.  But what defines a stem cell and provides them with their unique 
properties?  With the development of tools for global gene expression analyses over the 
past several years, researchers have attempted to answer this question by identifying a 
universal stem cell gene expression signature.  In 2002, two groups independently 
attempted to identify a so-called “stemness” signature by analyzing the expression 
profiles of mouse embryonic stem cells (ESCs), HSCs, and neural stem cells (NSCs) 
(Ivanova et al., 2002; Ramalho-Santos et al., 2002).  Both studies yielded a list of ~200 
stem cell specific genes that mouse ESCs, HSCs, and NSCs commonly expressed, but 
rather surprisingly, the results of the two studies showed minimal overlap.  
Approximately a year later, a third expression profiling study comparing ESCs, NSCs, 
and retinal progenitor/stem cells failed to uncover a unique stem cell fingerprint, with 
only one gene (Itga-6) being commonly identified among the three studies (Fortunel et 
al., 2003).  It is possible that the lack of overlap between the stem cell profiles identified 
in these studies was due to different experimental approaches.  Another possibility is that 
different stem cell types may use different gene networks to achieve self-renewal or 
multipotency, thus a universal stemness signature does not exist and cross tissue 
comparative expression analyses are not useful in identifying stem cell specific genes.   
 Perhaps a better way to determine a stemness profile is to compare the 
transcriptional profile of specific stem cells with that of their differentiated progeny.  
Chambers et al. recently performed this type of analysis by comparing the transcriptional 
profiles of HSCs, erythroid cells, granulocytes, macrophages, monocytes, natural killer 
cells, T cells, and B cells (Chambers et al., 2007a).  Although this expression database 
provided lists of genes exclusively expressed in specific hematopoietic cell types, the 
long list of HSC specific genes still makes it difficult to determine their individual and/or 
combined roles in stem cell function.    Thus it is necessary to combine expression 
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profiling with other genetic approaches in order to identify important HSC regulatory 
genes.   
 As mentioned previously, many hematopoietic traits are genetically controlled 
since they differ between various strains of inbred laboratory mice.  Due to the numerous 
hematopoietic differences that exist between B6 and D2 mice and the existence of BXD 
recombinant inbred (RI) mouse strains, we and others have identified numerous genomic 
regions (QTLs) affecting HSC traits (de Haan et al., 1997; de Haan and Van Zant, 1999; 
Muller-Sieburg and Riblet, 1996).  However, a major limitation of traditional QTL 
mapping approaches using RI reference panels is that they can only identify genomic 
regions of interest, often containing many genes.  It is hypothesized that polymorphic 
variants, often in the form of single nucleotide polymorphisms (SNPs), underlie 
phenotypic differences.  Since there are thousands upon thousands of SNPs in any one 
QTL region, and often multiple SNPs in any one gene, it is a daunting task to identify the 
polymorphism and therefore the gene that underlies a specific trait.  Thus it seems that 
strategies aimed at identifying important stem cell genes using expression profiling or 
genetic linkage analysis alone have proven to be difficult.  However, the combination of 
gene expression studies with genetic linkage analyses offers a promising approach for 
identifying specific genes that underlie HSC traits.    
In the present study, I performed genome wide gene expression analyses using a 
cell population enriched in stem and progenitor cells in order to identify genes located in 
the chromosome 2 QTL that influence HSC aging. DNA microarrays were used to 
identify genes that are differentially expressed between chromosome 2 congenic and B6 
background mice at young and old ages as well as after irradiation treatment. Although 
this approach makes the assumption that transcriptional regulation underlies the 
polymorphism, a significant proportion of the QTL that have been experimentally solved 
with QT gene identification to date have used this approach (Aitman et al., 1999; Flint et 
al., 2005; Karp et al., 2000; Klein et al., 2004; McBride et al., 2003; Rozzo et al., 2001). 
The congenic mouse model is a vital component in performing this type of experiment.  
Because the congenic animals have a genome that is approximately 99% B6 with the 
exception of the introgressed D2 interval, comparison of the number of differentially 
expressed genes between the two strains is greatly reduced compared to the number of 
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differentially expressed genes between D2 and B6 strains. This simplifies the process of 
identifying potential candidate genes that are responsible for the phenotype of interest. 
Another approach that combines genetics with gene expression analyses involves 
profiling gene expression patterns (using Affymetrix arrays) in recombinant inbred 
strains of mice (Bystrykh et al., 2005; Chesler et al., 2005).  The general idea is to treat 
mRNA levels as traditional quantitative traits.  This in turn allows you to detect and 
characterize QTLs that are linked to the variation in gene expression of individual 
transcripts.  QTLs that are responsible for variation in expression of transcripts can be 
classified into two groups: cis-acting QTLs which are located at the physical position of 
the transcript itself, and trans-acting QTLs that modulate the expression of large numbers 
of genes throughout the genome (Bystrykh et al., 2005).  This approach has recently been 
used to identify variation in gene expression patterns in HSCs isolated from the BXD RI 
strains.  This information is in a public database available at www.webqtl.org (Wang et 
al., 2003).  By searching for cis-regulated transcripts located in a QTL that controls a 
particular trait, it is possible to identify potential candidate genes that control the trait.  
Cis-regulated genes within QTLs represent the best candidate genes, as they may contain 
polymorphisms that affect both their own expression level as well as the trait of interest.  
Using the WebQTL database, it is possible to determine if differently expressed genes 
(obtained from microarray analyses) are cis-regulated.  I used this strategy to identify two 
novel candidate regulators of HSC aging.   
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Materials and Methods 
 
Animals 
Young (2-4 months) and old (24-25 months) C57BL/6 (B6) (Ptprcb [CD 45.2]) 
mice were purchased from the National Institute of Aging (NIA) Aged Mouse Colony at 
Harlan Sprague Dawley (Indianapolis, IN) and were used as the background strain.   
Chromosome 2 congenic mice, with a genetic interval from D2 mice spanning 50 Mbp  
(130Mbp -180 Mbp) on the distal end of chromosome 2, were generated as described 
previously (Geiger et al, 2005). Young (2-4 months) and aged (24-27 months) congenic 
animals were used in the experiments.   Genotypes of congenic animals were confirmed 
by PCR screening of genetic markers flanking the congenic interval and located 
throughout the genome.  All mice were female and were housed in the Division of 
Laboratory Animal Resources (DLAR) at the University of Kentucky Chandler Medical 
Center and were maintained under pathogen-free conditions according to NIH guidelines 
for animal welfare.  
 
Immunofluorescent staining of cells and flow cytometry 
Mice were euthanized by CO2 asphyxiation and the femora and tibiae were 
removed to a Petri dish containing Hanks Balanced Salt Solution (HBSS, GIBCO) 
supplemented with 2% fetal bovine serum (FBS, Invitrogen).  Femora and tibiae were 
flushed with 4 mL media to obtain a single cell suspension.  Mononucleated cells were 
obtained via Ficoll gradient separation and Fc receptors were subsequently blocked with 
anti-CD16/32 (clone 2.4G2, Fc Block) to prevent non-specific staining.  For Lineage 
negative (Lin-) isolation, cells were identified by the lack of cell surface antigens 
characteristic of cells committed to individual lineages of blood cell development.  The 
lineage cocktail consisted of the following antibodies: CD5 (clone 53-7.3) and CD8a 
(clone 53-6.7) to identify T cells, CD45R/B220 (clone RA3-6B2) to identify B cells, 
CD11b/Mac-1 (clone M1/70) and Ly-6G/Gr-1 (clone RB6-8C5) to identify macrophages, 
and Ter119/Ly-76 (clone Ter-119) to identify erythrocytes.  All antibodies were 
biotinylated and were further stained with streptavidin-fluorescein isothiocyanate (SA-
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FITC). Dead cells were excluded by propidium iodide (PI) staining.    For Lin- Sca+ c-
kit+ (LSK) cells, light density bone marrow cells were stained with the above lineage 
cocktail as well as stem cell specific cell surface markers, phycoerythrin (PE)-conjugated 
Ly-6A/E (Sca-1; cloneE13-161.7) and allophycocyanin (APC)-conjugated CD117 (c-kit; 
clone ne2B8).  The LSK population is highly enriched in stem cells.  Dead cells were 
excluded by PI staining.  All monoclonal antibodies were purchased from BD 
Pharmingen.  Cells were analyzed and sorted on a triple-laser FacsVantage  (Becton-
Dickinson) flow cytometer. 
 
Total RNA isolation 
For microarray analyses, total RNA was extracted from approximately 6x105 – 9x105 
sorted Lin- cells using RNeasy Kit (Qiagen, Valencia CA). Cells were sorted from the 
bone marrow of young (2-4 months) and old (24-25 months) B6 and congenic mice prior 
to and post 2 Gy of irradiation administered from a 137Cs source Mark 1 Irradiator (J.L. 
Shepherd and Associates) at a dose rate of 1.73 Gy per minute. Bone marrow cells were 
harvested, labeled, and Lin- cells were isolated by cell sorting.  RNA samples consisted 
of cells pooled from at least 5 mice for each age, strain and treatment group.  For 
quantitative real time PCR analyses, RNA was extracted from either 1x105 or 2x105 LSK 
and Lin- cells, respectively, using RNeasy kit (Qiagen, Valencia CA).  Lin- and LSK 
cells were sorted as described previously and all samples consisted of pooled cells from 
at least 5 mice for each stain and age.   
 
Microarray analysis of Lin- cells 
RNA samples were hybridized according to Affymetrix protocols onto Murine Genome 
430 2.0 arrays at the University of Kentucky Microarray Core Facility.  Briefly, RNA 
samples were reverse transcribed to cDNA, then cRNA was biotin-labeled, fragmented, 
and hybridized to the array. Three biological samples per experimental group were 
individually interrogated on separate Affymetrix M430 microarray chips resulting in a 
total of 24 arrays.  A 3-way ANOVA was used to analyze the results obtained from the 
three replicate chips for each sample group.  A statistical cutoff of P ≤ 0.01 was used and 
we set no limits on fold-change.  Two-way ANOVA’s were also performed to compare 
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expression levels when considering any two of the three variables.  Again, a statistical 
cutoff was set at P ≤ 0.01 and no limits were set on fold change.  
Quantitative real-time PCR 
RNA samples from young (2-4 months) and old (24-25 months) B6 and congenic mice 
were synthesized into cDNA by reverse transcription PCR.  The 100 µl reaction mixture 
consisted of sterile water, RNA, 10X RT buffer, MgCl2, deoxy NTPs, random hexamers, 
RNase inhibitor, and MultiScribe reverse transcriptase.  The cDNA samples were then 
used for real time PCR to validate the differential expression of specific genes.  cDNA 
synthesis was performed as above using a 20 ul reaction mix.  Taqman primers from 
Applied Biosystems were used according to manufacturer’s instructions for each real 
time PCR reaction.   Due to the fact that GAPDH expression changes with age in B6 and 
the congenic mice, the values obtained for the test gene were not normalized in Lin- and 
LSK cells.  Rather, equivalent numbers of cells were used in each experiment. We 
initially normalized gene expression to cDNA content, but found that it wasn’t necessary 
since similar values were obtained with non-normalized cDNA.  Samples for the 
derivation of standard curves and no-template controls were run in duplicate and 
experimental cDNA samples were run in quadruplicate using an ABI PRISM 7700 
Sequence Detector (PE Biosystems).   Each biological sample consisted of pooled cells 
from at least 5 mice and three replicate biological experiments were performed for each 
age and strain.   
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Results 
Identification of differentially expressed genes in chromosome 2 QTL by microarray 
analysis 
          
     I investigated the possibility that transcriptional differences between congenic and B6 
Lin- cells could point to candidate genes in the chromosome 2 QTL that contribute to two 
phenotypic polymorphisms that exist between the strains: HSC aging as well as 
sensitivity to low dose irradiation. Because the QTL congenic interval spans 50 Mb on 
chromosome 2, merging our linkage analysis with expressing profiling studies seemed to 
be a logical scientific approach to identify candidate genes that regulate the HSC 
phenotypes.  Three variables were examined: (a) the effect of strain—congenic vs. 
background (in which only approximately 1% of the genome was different); (b) the effect 
of age (2 months vs. 20+ months); and (c) the effects of 2 Gy of irradiation to compare 
our surrogate assay to natural aging (Figure 3.1).  Using a total of 24 Affymetrix 430 2.0 
chips in three replicate experiments, a total of 1,630 probes had a significant three-way 
interaction, i.e. the effect of one variable (strain) was dependent on the remaining two 
variables (age and treatment).  Another 1,922 probes were found to have significant two-
way interactions, and finally 3,279 probes were found to have what we refer to as a 
“significant main effect” (Figure 3.2).  That is, the differential expression of the probe 
was due independently to age, treatment, or stain.  Perhaps, not surprisingly, of the 3,279 
significant main effect probes, 1,215 had a significant age effect, 2,835 had a significant 
treatment effect, and only 725 probes had a significant strain effect.  In agreement with 
our hypothesis that irradiation, in this context, mimics aging, we found significant 
overlap in the age and irradiation treatment probesets, suggesting that irradiation damage 
causes similar transcriptional changes as does the natural aging process.  The smaller 
number of genes that had a significant strain effect reflects the fact that only 
approximately 1% of the genome is polymorphic between the background and congenic 
mice.  When 2-way ANOVAs (comparing B6 and congenic cells at young and old ages) 
were performed, both pre- and post- irradiation treatment, chromosome 2 had the highest 
number of differentially expressed probesets compared to all other chromosomes.  We 
also found that a large number of probesets located on chromosome 11 were 
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differentially expressed.  This may reflect the finding that a QTL regulating mouse 
lifespan has been mapped to this chromosome (de Haan et al., 1999).  An additional QTL 
regulating the natural variation in lifespan between B6 and D2 mice was also mapped to 
the same location on mouse chromosome 2 as the aging QTL, thus suggesting that genes 
regulating aging and/or the DNA damage response may overlap with, be clustered with, 
or influence those that affect lifespan.  The fact that a total of 6,831 (15% of the total 
45,101 probesets on the chip) probes were differentially expressed in the 3 way ANOVA 
suggests that aging and irradiation, in addition to a small difference in strain, have a 
profound effect on the transcriptional profiles of stem cells.  Moreover, the presence of 
differentially expressed genes located on chromosomes other than chromosome 2 
suggests that genes in the QTL regulate the expression of genes located elsewhere in the 
genome. 
 
Candidate QT gene identification 
Using the congenic mouse model, our search for candidate QT genes was greatly 
facilitated by allowing us to first focus our attention on genes physically located within 
the chromosome 2 QTL.  I searched for candidate genes that may regulate the different 
number of LSK cells in aged B6 and D2 mice by first identifying all significant 
transcripts on the Affymetrix arrays that mapped to the critical congenic interval (130 Mb 
- 150 Mb) on chromosome 2.  From 2-way and 3-way ANOVAs a total of 90 genes 
located within the chromosome 2 QTL were differentially expressed between the B6 and 
congenic mice (Table 3.1).  I then took advantage of the WebQTL database and searched 
for genetic loci that are strongly linked to the variation in gene expression of all 90 
individual differentially expressed transcripts present in the chromosome 2 QTL. The 
WebQTL database contains information comparing the strain distribution pattern of 
individual Affymetrix transcripts with the genetic distribution of B6 and D2 alleles at 779 
markers located throughout the genome (Bystrykh et al., 2005).  Performing this linkage 
analysis allowed me to map cis and trans regions of the genome that regulate the 
expression of the 90 transcripts located in the chromosome 2 congenic interval.  Six 
genes (Anapc1, Snrbp2, Rrbp1, Snx5, Rbl1, and Ndrg3) located in the interval were 
found to be cis-regulated and were also differentially expressed between B6 and D2 
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background strains according to other microarray experiments performed by our lab 
(Table 3.2).  Of the six genes, I chose to look more closely at sorting nexin 5 (Snx5) and 
retinoblastoma like protein-1 (otherwise known as p107) due to their strong cis regulation 
and because they had previously been linked to hematopoiesis and/or stem cell regulation 
(Vanderluit et al., 2004; Vanderluit et al., 2007).  Modifiers of Snx5 expression map to a 
genomic interval spanning from 139.4 Mb to 154.3 Mb on chromosome 2 (significant 
LRS linkage), a region containing D2Mit281 and D2Mit 282 (markers most tightly linked 
to the trait) and Snx5 (Figure 3.3).  Modifiers of p107 expression map to a genomic 
interval spanning from 156.5 Mb to 157.1 Mb on chromosome 2 (suggestive LRS 
linkage) containing p107 (Figure 3.4).  Snx5 (144 Mb) is located upstream from p107 
(156.8 Mb), thus there is a possibility that the genes to share a common promoter region 
(Figure 3.5).  However, this scenario is unlikely due to the large distance between the two 
genes, as well as the fact that both genes have fairly large CpG islands in their 5-prime 
regulatory regions.   
According to the microarray analysis, B6 alleles up-regulate both Snx5 and p107 
expression at both young and old ages compared to D2 alleles.  I next used real time PCR 
to confirm the differential expression of the genes in Lin- and LSK stem cell enriched 
populations.  Snx5 transcript levels were elevated in young and old B6 Lin- and LSK 
cells compared to congenic cells (Figure 3.6 A and B).  As expected, LSK cells from 
DBA mice also express lower levels of Snx5 when compared to B6 cells.  Similarly, 
p107 transcript levels were elevated in young and old B6 Lin- cells compared to 
congenics, but in LSK cells, p107 expression was significantly higher only in old B6 cells 
(Figure 3.7 A and B).  In young LSK cells, the inter-strain difference approached 
significance (P = 0.06) but was not as pronounced.  Again, old D2 LSK cells express 
lower levels of p107 when compared to old B6 cells, and we found no significant 
difference in p107 expression between old D2 and congenic LSK cells.  Thus, these data 
confirm the results obtained from the microarray analyses and suggest that Snx5 and 
p107 are positive regulators of stem cell number.  It is important to note that differential 
Snx5 and p107 expression are apparent in young mice (this is true for both genes in Lin- 
cells and for Snx5 in LSK cells), but the phenotypic effects entrained by lifelong 
differential expression do not become apparent until old age.  
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Discussion 
 
 Quantitative trait locus mapping studies have identified thousands of 
chromosomal regions containing genes that affect a wide variety of complex phenotypes 
ranging from alcoholism to diabetes and obesity.  However, identifying individual QTL 
genes has been slow and difficult over the past decade.  Fortunately, five years ago when 
I planned my dissertation project, new technologies such as the microarray, which 
allowed for comparative genomics, and the publication of the mouse and human genomic 
sequences set the stage for a new generation of QTL gene identification strategies.  In my 
studies, I used a combination of classical genetic linkage and microarray analyses to 
identify Snx5 and p107 as novel regulators of HSC frequency in mice.  Using microaray 
technology, I found that Snx5 and p107 genes were differentially expressed between 
young and old B6 and congenic Lin- cells.  Quantitative real time PCR was used to 
confirm these results in Lin- cells, as well as in more primitive LSK cells.        
The use of the chromosome 2 congenic mouse model was pivotal in performing 
this forward genetic approach to identify genes that regulate HSCs.  The congenic mice 
have a genome that is 99% B6 with the exception of the introgressed QTL interval from 
D2 mice.  The remaining 1% difference between the strains greatly reduced the number 
of differentially expressed genes between D2 and B6 parental strains.  A reciprocal 
congenic model in which the QTL interval was introgressed from B6 mice onto a D2 
genome was not available for these studies but would have further reduced the number of 
potential candidate genes, assuming the genes were reciprocally regulated (i.e. a gene 
would be upregulated in one congenic and down regulated in the reciprocal).  Another 
unique feature of the study is that cDNA amplification was not performed on any of the 
samples used in the microarray.  Because HSCs are such a rare cell type, other labs that 
have performed gene expression studies with these cells relied on in vitro amplification 
techniques (Ivanova et al., 2002; Ramalho-Santos et al., 2002). Amplification of cDNA 
by a standard PCR procedure may result in the differential amplification of particular 
transcripts, since sequences differ in the rate with which they can be amplified by PCR 
(Lockhart and Winzeler, 2000).  We obtained 500,000 Lin- cells from 5-10 mice for each 
strain, age and treatment group, and three independent biological samples were 
 75 
hybridized to individual chips.  Also, previous microarray studies relied on the use of 
Affymetrix U74Av2 chips, which contain only 12,488 probesets located throughout the 
mouse genome.  In these studies, I used Affyterix M430 chips that contain 45,000 
probesets, thus representing the entire mouse genome.  
 I used quantitative real time PCR to validate the differential expression of Snx5 
and p107 in Lin- as well as in primitive LSK cells.  Real time PCR is very sensitive, can 
distinguish between closely related mRNAs, and yields results that are quantitative in 
nature.  Due to its relative ease and convenience of use, real time PCR is the preferred 
method for validating microarray results compared to northern blotting and ribonuclease 
protection assays, which require large amounts of RNA.  Real time PCR confirmed that 
B6 alleles up-regulate Snx5 and p107 expression in young and old Lin- cells.  Because 
Lin- cells contain a mixture of stem and progenitor cells, I also performed real time PCR 
using LSK cells, which are highly enriched in stem cells.  I found that Snx5 expression 
was higher in young and old B6 LSK cells compared to congenic cells, whereas p107 
expression was only increased in old B6 LSK cells.  These results suggest that Snx5 and 
p107 are positive regulators of stem cell number and may regulate the HSC aging trait.   
The fact that B6 alleles increase the expression of Snx5 and p107 in young and old Lin- 
cells suggests that the rate of HSC aging may be due to lifelong differential expression of 
the genes.  Thus even though the genes are differentially expressed in young cells, the 
resulting phenotypic effects do not become apparent until old age.   
 Due to the large number of cells required for Western blot analysis, it was not 
possible to quantify protein levels of the genes in young and old Lin- or LSK cells.  I did 
however perform Western blots using whole bone marrow cells and found that the 
differential expression patterns observed above were reproduced for Snx5 but not for 
p107.  Because primitive HSCs comprise only 0.01% of the total bone marrow 
population, I was not surprised that I could not reproduce the expected expression 
patterns for p107 and thus did not allow these results to prevent further investigation on 
the role of this gene in hematopoiesis. 
 In order to determine the mechanisms that may contribute to the differential 
expression of p107 and Snx5 between B6 and congenic HSCs, I analyzed the transcripts 
for single nucleotide polymorphisms (SNPs) that exist between the two strains. The 
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presence of polymorphisms in coding or regulatory elements of transcripts can have a 
significant impact on gene expression levels as well as protein function, and thus can 
potentially effect phenotypic variation in organisms.   According to the Ensembl database 
(www.ensembl.org) B6 and D2 alleles of p107 have four non-synonymous SNPs located 
in coding regions as well as 16 intronic and seven 3’ untranslated region (UTR) SNPs 
(Figure 3.5).  The non-synonomous coding region SNPs are located in exons 9, 14, and 
15.  One SNP is located in region A of the pocket domain and two are located within the 
spacer region of the pocket domain.  The pocket domain consists of two conserved 
sequences, A and B, which are separated by a spacer domain.  This “pocket” is 
responsible for mediating interactions with viral-oncoproteins as well as other cellular 
proteins to carry out the biological function of this protein.  Traditionally it is held that 
the differential expression of a gene is caused by altered transcription factor binding due 
to the presence of SNPs in regulatory regions (most notably 5’UTR promoter regions) 
upstream of the gene.  Although we did not detect any SNPs in the 5’ UTR region of 
p107 emcompassing 800 base pairs upstream of the start codon, the exonic SNPs located 
in the functional pocket domain of p107 have the potential to affect transcript stability, 
which could result in the differential expression of the gene in a cellular context.  Further, 
although not yet studied, the presence of SNPs in the 3’ UTR of p107 could also affect its 
expression.  Indeed, Clop et al. identified a QTL on chromosome 2 that effects muscle 
mass in sheep and showed that a point mutation in the 3’ UTR of the myostatin (GDF8) 
gene (located in the QTL) created a target site for miRNAs.  They then demonstrated that 
differential miRNA binding to the transcript resulted in differential myostatin protein 
expression (Clop et al., 2006).  There are a total of 15 predicted murine microRNA 
binding sites in the 3’ UTR of p107 as identified by PicTar WEB INTERFACE (Krek et 
al., 2005).   Benetti et al. recently showed that the p107-related protein, Rbl2 (p130), is 
transcriptionally down-regulated by the mir290 cluster of miRNAs (Benetti et al., 2008).  
It is therefore conceivable that the expression of other members of the retinoblastoma 
family are regulated in a similar fashion.  
In order to identify SNPs between B6 and congenic mice located in the Snx5 
transcript, I again used the Ensembl database.  I found that there are 8 3’UTR SNPs and 8 
intronic SNPs between B6 and D2 mice in Snx5 (Figure 3.5). Although this gene does 
 77 
not have any SNPs located in its coding region, it is possible that some of the intronic 
SNPs may modify Snx5 expression.  Also, using the PicTar WEB INJTERFACE, I found 
7 predicted murine microRNA binding sites in the 3’ UTR of Snx5, thus it’s possible that 
SNPs located in the 3’ UTR may modulate Snx5 expression.   
In order to identify cis- and trans-acting factors that affect the expression of p107 
and Snx5, I used WebQTL software, which contains a quantitative gene expression 
database in LSK stem cells of all BXD mouse strains. This database allows one to map 
the regions of the genome that modify the expression of genes of interest (Bystrykh et al., 
2005).  I found that both Snx5 and p107 are cis- regulated, meaning that modifiers of 
their expression map very close to the actual gene itself.  In addition, negative additive 
effects indicate that B6 alleles increase the trait values (p107 and Snx5 expression), 
which is consistent with the results obtained from microarray and real time-PCR 
experiments.  These results therefore suggest the existence of regulatory factors in the 
proximal regions surrounding p107 and Snx5, and further support our hypothesis that 
these genes are directly or indirectly responsible for the phenotypes conferred by the 
chromosome 2 QTL.   
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Figure 3.1 Microarray experimental design. 
Schematic illustrating the experimental design of the microarray analysis.  Using B6 and 
congenic mice at young and old ages allows for the identification of both inter- and intra-
strain changes in gene expression that accompany aging. We chose to use non-irradiated 
as well as irradiated mice in order to test our surrogate assay to natural aging.  A total of 
24 arrays (3 for each strain, age, and treatment group) were used. 
 
 
 
 
 
Congenic 
B6 
Old (24-25 mo.) Young (2-4 mo.) 
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Figure 3.2 Flow Chart of Microarray Data Analysis. 
A total of 6,831 probe sets were found to be significant with a p-value of ≤ 0.01.  The 
probesets were further divided into three categories: 1) probesets significant for a 3-way 
interaction, 2) probesets significant for a 2-way interaction, and 3) probesets significant 
for a main effect.   
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Probe Set ID Gene Title Chromosome P-value 
1450698_at dual specificity phosphatase 2 2 F1 0.00035 
1427496_at expressed sequence AI851464 2 F1 0.00970 
1444524_at LOC433475 2 F1 0.00035 
1449445_x_at microfibrillar-associated protein 1 2 F1 0.00970 
1458358_at pantothenate kinase 2 (Hallervorden-Spatz syndrome) 2 F1 0.00101 
1453055_at 
sema domain, transmembrane domain (TM), and cytoplasmic 
domain, (semaphorin) 6D 2 F1 0.01041 
1424268_at spermine oxidase 2 F1 0.00087 
1446807_at Ubiquitin specific protease 8 2 F1 0.00428 
1418495_at zinc finger CCCH type domain containing 8 2 F1 0.00012 
1419270_a_at deoxyuridine triphosphatase 2 F1|2 70.0 cM 0.00072 
1437193_s_at small nuclear ribonucleoprotein B 2 F1|2 73.0 cM 0.00083 
1434197_at attractin 2 F1|2 73.9 cM 0.00576 
1421811_at thrombospondin 1 2 F1-F3|2 65.0 cM 0.00103 
1416800_at 
transient receptor potential cation channel, subfamily M, 
member 7 2 F2 0.00600 
1438957_x_at 
CDP-diacylglycerol synthase (phosphatidate 
cytidylyltransferase) 2 2 F2|2 73.0 cM 0.00093 
1448233_at prion protein 2 F2|2 75.0 cM 0.00000 
1434443_at Anaphase promoting complex subunit 1 2 F3 0.00038 
1451505_at coiled-coil-helix-coiled-coil-helix domain containing 5 2 F3 0.00160 
1426533_at nucleolar protein 5A 2 F3 0.00015 
1428580_at biliverdin reductase A 2 F3|2 62.0 cM 0.00118 
1448534_at protein tyrosine phosphatase, non-receptor type substrate 1 2 F3|2 73.1 cM 0.00052 
1435449_at BCL2-like 11 (apoptosis facilitator) 2 F3-G1 0.00001 
1452767_at ribosome binding protein 1 2 G1 0.00009 
1426613_a_at U2 small nuclear ribonucleoprotein B 2 G1 0.00409 
1419202_at cystatin F (leukocystatin) 2 G1-G3 0.00083 
1433607_at cerebellin 4 precursor protein 2 G3 0.00096 
1448184_at FK506 binding protein 1a 2 G3 0.00085 
1451337_at proteasome (prosome, macropain) inhibitor subunit 1 2 G3 0.00271 
1422842_at 5'-3' exoribonuclease 2 2 H1 0.00088 
1419038_a_at casein kinase II, alpha 1 polypeptide 2 H1 0.00000 
1426765_at COMM domain containing 7 2 H1 0.00001 
1441931_x_at glutathione synthetase 2 H1 0.00289 
1417941_at haloacid dehalogenase-like hydrolase domain containing 4 2 H1 0.00019 
1431431_a_at nitrogen fixation gene 1 (S. cerevisiae) 2 H1 0.00375 
1417664_a_at N-myc downstream regulated gene 3 2 H1 0.00600 
1416059_at SEC23B (S. cerevisiae) 2 H1 0.00340 
1424308_at 
solute carrier family 24 (sodium/potassium/calcium 
exchanger), member 3 2 H1 0.00550 
1434400_at TGFB-induced factor 2 2 H1 0.01041 
1423080_at 
translocase of outer mitochondrial membrane 20 homolog 
(yeast) 2 H1 0.00149 
1423204_at transmembrane 9 superfamily protein member 4 2 H1 0.00039 
1428402_at zinc finger, CCHC domain containing 3 2 H1 0.00477 
1417648_s_at sorting nexin 5 2 H1|2 80.0 cM 0.00000 
1417124_at destrin 2 H1|2 81.4 cM 0.00025 
1418244_at N-acetyltransferase 5 (ARD1 homolog, S. cerevisiae) 2 H1|2 82.0 cM 0.00110 
1425895_a_at inhibitor of DNA binding 1 2 H1|2 84.0 cM 0.00072 
1428820_at microtubule-associated protein, RP/EB family, member 1 2 H1|2 84.0 cM 0.00013 
1449455_at hemopoietic cell kinase 2 H1|2 86.0 cM 0.00064 
1417500_a_at transglutaminase 2, C polypeptide 2 H1|2 89.0 cM 0.00000 
1448820_a_at eukaryotic translation initiation factor 2, subunit 2 (beta) 2 H1|2 90.0 cM 0.00108 
1420664_s_at protein C receptor, endothelial 2 H1-3 0.00464 
1422479_at acetyl-Coenzyme A synthetase 2 (ADP forming) 2 H2 0.00411 
1448626_at CDK5 regulatory subunit associated protein 1 2 H2 0.00077 
1455080_at protein phosphatase 1, regulatory (inhibitor) subunit 16B 2 H2 0.00007 
Table 3.1. Differentially expressed probesets between B6 and congenic 
mice located within the chromosome 2 QTL   
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1434438_at SAM domain and HD domain, 1 2 H2 0.00524 
1456867_x_at serologically defined breast cancer antigen 84 2 H2|2 92.0 cM 0.00499 
1448582_at catenin, beta like 1 2 H2|2 94.0 cM 0.00249 
1458039_at Nuclear receptor coactivator 3 2 H2-H4 0.00309 
1424161_at DEAD (Asp-Glu-Ala-Asp) box polypeptide 27 2 H3 0.00017 
1417068_a_at protein tyrosine phosphatase, non-receptor type 1 2 H3 0.00029 
1436015_s_at serine/threonine kinase 4 2 H3 0.00371 
1420054_s_at solute carrier family 35, member C2 2 H3 0.00103 
1430388_a_at sulfatase 2 2 H3 0.00519 
1448345_at translocase of outer mitochondrial membrane 34 2 H3 0.00642 
1424511_at aurora kinase A 2 H3|2 100.0 cM 0.00953 
1458501_at 
vesicle-associated membrane protein, associated protein B 
and C 2 H3|2 103.0 cM 0.00900 
1424411_at expressed sequence AI840826 2 H3|2 49.6 cM 0.00220 
1427844_a_at CCAAT/enhancer binding protein (C/EBP), beta 2 H3|2 95.5 cM 0.00605 
1437414_at zinc finger protein 217 2 H3|2 99.0 cM 0.00138 
1439802_at Serine/threonine kinase 35 (Stk35), mRNA chr2 F1 0.00058 
1425349_a_at myelin basic protein expression factor 2, repressor chr2 F1|2 73.0 cM 0.00058 
1452428_a_at beta-2 microglobulin chr2 F1-F3|2 69.0 cM 0.00330 
1438957_x_at 
CDP-diacylglycerol synthase (phosphatidate 
cytidylyltransferase) 2 chr2 F2|2 73.0 cM 0.00977 
1417947_at proliferating cell nuclear antigen chr2 F2|2 75.0 cM 0.00000 
1416985_at protein tyrosine phosphatase, non-receptor type substrate 1 chr2 F3|2 73.1 cM 0.00004 
1416174_at retinoblastoma binding protein 9 chr2 G1-H1 0.00107 
1429328_at NSFL1 (p97) cofactor (p47) chr2 G3 0.00000 
1422488_at NTF2-related export protein 1 chr2 H1 0.00730 
1433826_at TSPY-like 3 chr2 H1 0.00047 
1425166_at Retinoblastoma-like 1 (p107) chr2 H1 0.00003 
1420631_a_at bladder cancer associated protein homolog (human) chr2 H1|2 88.0 cM 0.00437 
1447898_s_at splicing factor, arginine/serine-rich 6 chr2 H2|2 79.8 cM 0.00636 
1424767_at cadherin 22 chr2 H3 0.00401 
1434069_at cDNA sequence BC067047 chr2 H3 0.00007 
1448847_at tumor differentially expressed 1 chr2 H3 0.00071 
1429947_a_at Z-DNA binding protein 1 chr2 H3 0.00000 
1452954_at ubiquitin-conjugating enzyme E2C chr2 H3|2 93.0 cM 0.00020 
1417976_at adenosine deaminase chr2 H3|2 94.0 cM 0.00000 
1430288_x_at ribosomal protein S21 chr2 H4 0.00004 
1441923_s_at endothelin 3 chr2 H4|2 104.0 cM 0.00137 
1417786_a_at regulator of G-protein signaling 19 chr2 H4|2 45.0 cM 0.00019 
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A total of six cis regulated genes located in the congenic interval were found to be 
differentially expressed between young and old B6 and congenic mice as well as between 
B6 and DBA mice.  RNA isolated from B6 and chromosome 2 congenic Lin- cells was 
labeled and hybridized to Affymetrix Mouse Genome 430 chips.  Three independent 
experiments from three treatment groups (strain, age, and irradiation treatment) were 
used to quantify differential expression patterns.      
 
 
 
 
 
 
 
 
 
Probe ID Gene Name Gene 
Symbol 
Location 
(Mb) 
Function 
1434443_at 
 
Anaphase promoting complex 1 Anapc1 128.4 Mb regulation of cell cycle 
1426613_a_at 
 
U2 small nuclear 
ribonucleoprotein B 
 
Snrbp2 142.8 Mb nuclear mRNA splicing, 
mRNA processing 
1452767_at 
 
ribosome binding protein 1 
 
Rrbp1 143.7 Mb protein targeting and transport 
1417648_s_at 
 
Sorting nexin 5 
 
Snx5 144.0 Mb intracellular signaling, 
protein transport/trafficking 
1425166_at 
 
Retinoblastoma like protein 1 Rbl1 156.8 Mb cell differentiation 
1417663_a_at 
 
N-myc downstream regulated 
gene 3 
Ndrg3 156.9 Mb negative regulation cell cycle, 
negative regulation of transcription 
Table 3.2 Differentially expressed cis regulated genes in the chromosome 2 QTL 
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Figure 3.3 Cis-acting quantitative trait loci that modulate Snx5 expression. 
Using WebQTL, we found a QTL on chromosome 2 that influences Snx5 expression. 
The genomic interval spans from 139.4 Mb to 154.3 Mb on chromosome 2 and reaches 
significant LRS threshold.  The orange tick marks on the bottom of the figure represent 
SNPs across chromosome 2.  The area surrounding Snx5 is highly polymorphic between 
B6 and DBA mice.   
 
 
 
 
 
 
 
 
Chromosome 2 
Significant  
LRS Threshold 
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Figure 3.4  Cis-acting quantitative trait loci that modulate p107 expression.   Using 
WebQTL, we found a QTL on chromosome 2 that influences p107 expression. The 
genomic interval spans from 156.5 Mb to 157.16 Mb on chromosome 2 and reaches 
suggestive LRS threshold.  The orange tick marks on the bottom of the figure represent 
SNPs across chromosome 2.  Again, the area surrounding p107 is highly polymorphic 
between B6 and DBA mice.   
 
 
 
 
 
 
 
 
 
Suggestive  
LRS Threshold 
Chromosome 2 
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Figure 3.5 Location of Snx5 and p107 within the congenic interval. 
p107 and Snx5 are transcribed from the minus strand on chromosome 2.  Shown here are 
8 SNPs located within the 3’ regulatory region of Snx5 and seven SNPs in the 3’ UTR of 
p107 as well as 4 non-synomous coding region SNPs.   
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Figure 3.6 Differential expression of Snx5 mRNA in Lin- and LSK cells. 
200,000 Lin- cells were sorted from young and old mice and mRNA levels were 
measured by real time PCR.  Snx5 mRNA levels are significantly higher in young and 
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old B6 Lin- cells compared to congenic cells (P ≤ 0.01) (A).  100,000 LSK cells were 
sorted from young and old animals and mRNA levels were measured by real time PCR.  
Snx5 mRNA levels are significantly higher in young B6 LSK cells compared to congenic 
cells (P≤ 0.01).  I detected no significant difference in Snx5 expression in young DBA 
cells compared to young B6 and congenic cells.  Snx5 mRNA expression is significantly 
higher in old B6 LSK cells compared to old congenic and old DBA LSK cells (P ≤ 0.05) 
(B). Results are given as mean ± SEM (n ≥ 5 mice per experiment, 12 measurements 
from 3 replicate experiments).   
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Figure 3.7 Differential expression of p107 mRNA in different HSC compartments.  
200,000 Lin- cells were sorted from young and old mice and mRNA levels were 
measured by real time PCR.  p107 mRNA levels are significantly higher in young and old 
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B6 Lin- cells compared to congenic cells (P ≤ 0.01) (A).  100,000 LSK cells were sorted 
from young and old animals and mRNA levels were measured by real time PCR.  p107 
mRNA levels are not significantly different between the three strains in young LSK cells.  
However, p107 mRNA expression is significantly higher in old B6 LSK cells compared 
to old congenic and DBA LSK cells (P ≤ 0.05) (B).  Results are given as mean ± SEM (n 
≥ 5 mice per experiment, 12 measurements from 3 replicate experiments).   
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CHAPTER FOUR 
 
Functional effect of retroviral overexpression of p107 and Snx5 in murine HSCs  
 
Summary 
  
In order to determine whether p107 and Snx5 expression influence HSC 
frequency, I used retroviral vectors to overexpress both genes in congenic HSCs.  I 
constructed individual vectors containing p107 and Snx5 cDNA and transfected these as 
well as an empty vector control into young congenic bone marrow cells.  Using GFP to 
identify transduced cells, p107, Snx5, and empty vector control cells were sorted using 
flow cytometry and subsequently used for in vitro cobblestone area forming cell assays 
CAFC).  Upon performing CAFC assays, I showed that congenic HSCs overexpressing 
p107 increased the frequency of day21, day28, and day35 CAFCs compared to cells 
expressing the empty vector control.  Similarly, congenic HSCs overexpressing Snx5 
increased the frequency of day14, day21, and day35 CAFCs compared to cells expressing 
the control vector.  These results provide strong evidence that p107 and Snx5 are positive 
regulators of HSC number and suggest that life-long elevated expression of the genes 
(such as that seen in B6 HSCs) may protect the stem cell compartment and delay the 
signs of aging in this vital cell population.  Although not available at the time when the 
dissertation was under preparation, functional CRU assays in which I measure the in vivo 
frequency of congenic HSCs transduced with p107 or Snx5, are being performed to 
investigate the role of each gene’s expression on HSC number.  As HSC expansion 
techniques have not proven very effective, the data presented here may be useful for the 
development of new strategies to expand HSCs in the clinic.          
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Introduction 
 
The murine hematopoietic system is the best-characterized mammalian stem cell 
model despite the fact that HSCs are inherently rare cells types.  This is due in part to the 
widespread use of gene transfer techniques in which the gene of interest is delivered into 
target cells under the control of a retroviral promoter.   Retroviral-mediated gene transfer 
techniques have been used extensively in HSC biology, and have identified numerous 
genes that are vital for the proliferation, differentiation and self-renewal of HSCs. 
This methodology can be used to reconstitute a defective function or to analyze protein 
function during hematopoiesis by overexpression.  In my studies I employ the latter and 
determine the effect of p107 and Snx5 overexpression on the number of HSCs in B6 and 
congenic mice.   
Retroviral vectors are appealing vehicles for gene transfer for several reasons: 1) 
they stably integrate into host chromosomal DNA, 2) they deliver genes to target cells at 
high efficiency and allow for long-term, stable expression of introduced genetic elements, 
and 3) the retroviral promoter can direct high-level, efficient gene expression. 
The main advantage of using retroviruses when manipulating hematopoietic cells is that 
they integrate into the host genome and therefore are transmitted to progeny through cell 
division.  This ensures that the retrovirus construct remains present and continues to 
express the gene of interest in differentiated progeny of HSCs that were originally 
infected.  In this regard, bone marrow cells can be harvested, manipulated in vitro, and 
either be used for in vitro HSC assays or transplanted back into conditioned recipient 
mice (where they will reconstitute the entire blood system of the recipient), thus making 
it possible to study how the overexpression of a gene affects the entire hematopoietic 
system.   
In our lab, we use Phoenix helper-free retrovirus producer lines to package 
retroviral particles.  The Phoenix packaging cell lines were created by placing cell 
constructs capable of producing gag-pol and envelope protein for ecotrophic and 
amphotrophic viruses into the 293T cell line.  The 293T cell line is an easily transfectable 
human embryonic kidney line transformed with adenovirus E1a and carrying a 
temperature-sensitive T antigen co-selected with neomycin (Graham et al., 1977). 
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Packaging cells provide the structural and regulatory proteins required in trans for 
assembling a viral particle.  Retroviral vectors carry only cis elements necessary to 
facilitate packaging, reverse transcription, and integration.  This is important because 
once transduced, the retroviral vector is unable to replicate.   
 Infection of HSCs by retroviral vectors is dependent on numerous factors, including 
cycling status of the target cell population, the specific infection protocol used, and pre-
stimulation of the cells to growth stimulatory factors before infection.  It is vital to 
preserve the functional qualities of HSCs during the period of in vitro manipulation since 
down stream assays require intact functional capabilities of HSCs. In order to achieve 
successful retroviral transduction, the target cells must be actively replicating at the time 
of infection (Miller et al., 1990). Since HSCs are a relatively quiescent population, it is 
necessary to pre-treat donor animals with 5-fluorouracil (5-FU), a cytotoxic drug that acts 
as a pyrimidine antagonist.  5-FU functions to inhibit DNA synthesis both by blocking 
the formation of normal pyrimidine nucleotides via enzyme inhibition and by interfering 
with DNA synthesis after incorporation into a growing DNA molecule, thus it selectively 
kills hematopoietic progenitor cells that are actively cycling while sparing the primitive 
HSC population.  In response to the elimination of progenitor cells, the HSCs begin to 
cycle, thus allowing retroviral gene transfer studies to be performed in this cell 
population. Additional studies with hematopoietic cells show that gene transfer efficiency 
is improved when the HSCs are pre-stimulated with growth factors (Lim et al., 1989). 
Particularly, pretreatment in vitro of donor cells from 5-FU treated mice with the 
combination of interleukin 3 (IL-3), IL-6, and stem cell factor (SCF) greatly improves 
gene transfer efficiency (Luskey et al., 1992).  In my hands, I usually achieve 8-10% 
infection efficiency of primary HSCs, thus even with enhanced transduction protocols, it 
is still very difficult to obtain large numbers of transduced cells.   
  The efficiency of gene transfer varies considerably and not all target cells become 
infected.  This results in a mixed population of transduced and non-transduced cells, 
therefore it is necessary to tag your vector with a selectable marker that allows for the 
distinction between infected and non-infected cells.  For my experiments, I used a 
retroviral vector (Sfbeta 91) that contained green fluorescent protein (GFP) placed under 
internal ribosome entry sequence (IRES) translation.  The gene of interest and GFP are 
 93 
co-transcribed into a single mRNA encoding both genes from the same promoter.  Protein 
synthesis is achieved by cap driven translation of the first gene and IRES driven 
translation from the second cistron (Haviernik et al., 2008).  Cells that express the gene 
will also express GFP, thus making it possible to isolate the cells of interest for use in 
functional experiments.  In my experiments, I individually cloned the coding sequences 
of p107 and Snx5 into the Sfbeta 91 vector.  Primary HSCs transduced with these vectors 
were then used for in vitro CAFC experiments.        
p107 is a member of the reintoblastoma (Rb) family of proteins, which include 
pRb and p130 (Classon et al., 2000).  pRb is the best known member of this pocket 
protein family, and was the first tumor suppressor gene to be identified and cloned (Lee 
et al., 1987; Sparkes et al., 1983).  Members of the pRb family are structurally similar, 
with greatest homology lying in a pocket domain that mediates interaction of the proteins 
with the E2F family of transcription factors as well as with viral oncoproteins (Classon 
and Dyson, 2001).  Studies examining mice with targeted mutations in pRb genes suggest 
that the three proteins have overlapping functions (Clarke et al., 1992; Jacks et al., 1992; 
Lee et al., 1992; Lee et al., 1994), the most prominent of which is to regulate cell 
proliferation by negatively regulating the activity of E2F transcription factors.  
Hypophosphorylated pRb proteins bind to members of the E2F family of transcriptional 
regulators and block E2F proteins from activating genes involved in cell cycle 
progression (Nevins, 1992).  However, unlike pRB, mutations in p107 and p130 are not 
frequently observed in human cancers, thus suggesting that the proteins have at least 
some non-redundant functions.  Vanderluit et al. looked specifically at the role of p107 in 
neural stem cells, and consistent with its role as a growth suppressor, found that it 
negatively regulates the number of neural stem cells in both the developing and adult 
brain (Vanderluit et al., 2004).  Additional studies by Kondo et al. used a non-
phosphorylatable and thus constitutively active p107 to demonstrate that it can inhibit S 
phase progression a BaF3-derived mouse pro-B cell line (6-1 cells) (Kondo et al., 2001).  
They also show that the exposure of cells to cisplatin, a DNA-damaging agent, causes S 
phase arrest, which is associated with the accumulation of hypophosphorylated p107, and 
thus conclude that p107 participates in inhibition of S phase progression in response to 
DNA damage (Kondo et al., 2001).  I hypothesize that overexpression of p107 in bone 
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marrow cells exposed to irradiation (i.e. cellular stressor) will force them to arrest at G1, 
thus allowing cells time to repair damage, enter a senescent state, or undergo apoptosis.  
Over the lifetime of the animal, this intact cell cycle checkpoint would prevent DNA 
damage accumulation in the stem cell compartment and thus would ensure long-term 
function of the hematopoietic system.  Several labs have studied the functional role of 
pRB in the HSC compartment, but limited data exists on the role of p107 in 
hematopoiesis (Daria et al., 2008; Spike et al., 2004; Spike and Macleod, 2005; Walkley 
and Orkin, 2006).  In order to determine the effect of p107 overexpression on the 
regulation of HSC numbers, I constructed the aforementioned retroviral vector containing 
p107 and overexpressed this gene in congenic bone marrow cells enriched in HSCs.   
The other candidate gene uncovered in the microarray analysis, Snx5, is a 
member of a large family of sorting nexin proteins that are involved in various aspects of 
endocytosis and protein trafficking (Worby and Dixon, 2002).   The Snx5 protein has 
been reported to bind the Fanconi anemia complementation group A (FANCA) protein, 
and increased expression of Snx5 in cells increases FANCA protein levels (Otsuki et al., 
1999).  Eleven Fanconi anemia (FA) genes have been identified, and collectively the 
proteins function to regulate how cells recognize and repair DNA damage (Mathew, 
2006).  It has been shown that FA genes are highly expressed in primitive hematopoietic 
cells, suggesting the genes may be involved in maintenance of the stem cell pool and/or 
differentiation (Aube et al., 2003).  The Fanconi anemia syndrome is a rare recessive 
genetic disorder characterized by chromosomal fragility, bone marrow failure, and 
predisposition to cancer.  The altered DNA repair and damage response phenotype of this 
syndrome is shared by several accelerated aging syndromes including Bloom,Werner, 
and ataxia telangiectasia (Zhang et al., 2007).  I hypothesize that Snx5 controls cellular 
levels of FANCA, thereby facilitating the cells ability to respond to and/or repair DNA 
damage.  Reduced levels of Snx5, and possibly FANCA, in aged congenic stem cells 
(and young cells exposed to radiation) may dampen DNA response/repair pathways, thus 
leading to senescence, cellular aging, and stem cell depletion.   
In addition to binding the FANCA protein, Snx5 has also been shown to 
translocate to the plasma membrane in response to Epidermal growth factor (EGF) 
stimulation and inhibit EGF receptor (EGFR) degradation (Liu et al., 2006; Merino-Trigo 
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et al., 2004).  Recently it has been shown that EGFR is phosphorylated and activated 
after cellular stressors such as irradiation (Dittmann et al., 2005).  Upon activation, 
EGFR translocates to the nucleus where it binds and activates DNA-dependent protein 
kinase (DNA-PK), which mediates non-homologous end joining (NHED) to repair DNA 
double strand breaks (Bandyopadhyay et al., 1998; Dittmann et al., 2005; Lin et al., 
2001).  It is possible that increased Snx5 expression aids in the stabilization of EGFR, 
which in turn results in enhanced DNA repair capacity in the face of damage. Thus, 
decreased Snx5 expression in congenic HSCs may result in reduced DNA repair 
efficiency, which explains why they are extremely sensitive to 2 Gy of irradiation.    
In order to determine the effect of Snx5 overexpression on HSC number, I 
constructed a second retroviral vector encoding Snx5 and overexpressed this gene in 
congenic bone marrow cells enriched in HSCs.  It was not possible to overexpress p107 
and Snx5 in old congenic cells due to large number animals that this task would require.  
It takes approximately 12 young mice to yield enough cells (2-4 x 106 cells) to be injected 
into one recipient mouse.  Since the experiments were performed in triplicate and 
quadruplicate, it would require nearly 100 old congenic mice to perform these 
experiments.  I maintain an active congenic breeding colony in the DLAR at the 
University of Kentucky, therefore making it possible for me to obtain enough young mice 
for the completion of these studies.     
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Materials and Methods 
 
Animals 
Young (2-4 months) C57BL/6 (B6) (Ptprcb [CD 45.2]) mice were purchased from the 
National Institute of Aging (NIA) Aged Mouse Colony at Harlan Sprague Dawley 
(Indianapolis, IN) and were used as recipients of GFP+ cells.  The mice served as in vivo 
“incubators” to expand infected cells for use in CAFC assays.  Chromosome 2 congenic 
mice were generated as described previously (Geiger et al., 2005).  The congenic interval 
spans 50 Mbp  (130Mbp -180 Mbp) on the distal end of chromosome 2.  All mice were 
female and were housed in the Division of Laboratory Animal Resources (DLAR) at the 
University of Kentucky Chandler Medical Center and were maintained under pathogen-
free conditions according to NIH guidelines for animal welfare.  
 
Retroviral vectors 
The coding regions of the genes were subcloned into the multi-cloning site of the 
retroviral vector Sfbeta 91.  The Sfbeta 91 backbone served as a control.  Sfebta 91 
contained a myeloproliferative sarcoma virus (MSFV)-derived 5’ long terminal repeat 
(LTR) and a spleen focus forming virus (SFFV)-derived 3’LTR.  It also contained an 
internal ribosome entry site (IRES) derived from the encephalomyocarditis virus which 
ensured simultaneous translation of the gene insert and the enhanced green fluorescent 
protein (GFP) reporter gene.    The gene cDNA sequence was cloned upstream of the 
IRES in Sfbeta 91, to yield the recombinant the vectors, MSFV-p107-IRES-GFP-SFFV 
(p107GFP+) and MSFV-Snx5-IRES-GFP-SFFV (Snx5/GFP+).  The recombinant vectors 
were transfected into Phoenix helper-free packaging cells using a calcium phosphate 
precipitation method.  Production of high-titer retrovirus was carried out according to 
standard procedures in the Phoenix packaging cells. 
Infection of primary bone marrow cells 
Primary bone marrow cells were harvested as described above from young congenic mice 
that had been injected intraperitoneally with 150 mg per kg of body weight of 5-
fluorouracil (5-FU)  (Sigma-Aldrich) 4 days prior to harvest.   Cells were then cultured 
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over night in Iscove’s Modified Dulbecco’s Medium (IMDM) supplemented with 10% 
FBS, 1% penicillin/streptomycin, 50 ng/mL recombinant mouse stem cell factor (mSCF), 
10 ng/mL mouse interleukin 6 (mIL-6), and 10 ng/ml mouse interleukin 3 (mIL-3) (R&D 
Systems).  Cells were subsequently harvested and placed onto transwell membranes 
(Corning Incorporated Life Sciences) at a density of 2x106 cells per well.  Viral 
supernatants plus 50 ng/mL mSCF, 10 ng/mL mIL-6, 10 ng/mL mIL-3, and 4 ug/mL 
polybrene were added to the cells.  Fresh supernatant (plus cytokines and polybrene) was 
added to the cells 4 times over a period of 48 hours.  The infected cells were then 
harvested and transplanted into sub-lethally irradiated (6 Gy) B6 mice at a dose of 2x106- 
4x106 cells per mouse to repopulate the myeloablated tissues.    
 
Isolation of GFP+ cells 
Twelve weeks post transplant, mice injected with infected cells were euthanized by CO2 
asphyxiation and the femora, tibiae, and humeri were removed to a Petri dish with Hanks 
Balanced Salt Solution (HBSS, GIBCO) supplemented with 2% fetal bovine serum (FBS, 
Invitrogen) (media).  Humeri were used in order to isolate the maximum amount of bone 
marrow from the mice.  Bones were flushed with 4 mL media to obtain a single cell 
suspension.  Erythrocytes in the bone marrow were eliminated by hypotonic lysis and the 
cells were washed with media.  GFP+ (empty vector, p107/GFP+, Snx5/GFP+) cells were 
sorted from bone marrow on a FACS Vantage cell sorter (Becton-Dickinson) and were 
used for cobblestone area forming cell (CAFC) assays.  Frequencies of CAFCs were 
calculated using maximum likelihood analysis with L-Calc software (Stem Cell 
Technologies).  Frequencies equal one divided by the number of cells yielding 37% 
negative wells. 
 
CAFC Assay for functional analysis of retrovirally transduced cells 
Equal numbers of GFP+ retrovirally transduced cells (empty vector, p107/GFP+, 
Snx5/GFP+) were sorted from primary recipient mice 12 weeks after initial transplant.  
The CAFC assay was carried out as described previously (de Haan et al., 1997; Geiger et 
al., 2001) with slight modifications described below.  FBMD-1 stromal cells were plated 
in a 96-well tissue culture plate 7-10 days before the start of the assay to form a confluent 
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layer.  After 7-10 days, 20 replicate wells were seeded with GFP+ cells at cell doses of 
81,000, 27, 000, 9000, 3000, 1000, or 333 cells per well.   In circumstances where it was 
not possible to sort enough cells for six dilutions, cells were seeded at doses of 27, 000, 
9000, 3000, 1000, or 333 cells per well.  The cell culture media contained IMDM 
(GIBCO) plus 20% horse serum, 80 U/ml penicillin, 80 mg/ml streptomycin (Life 
Technologies), and 0.1 mM each of B-mercaptoethanol and hydrocortisone (Sigma-
Aldrich).   Individual wells were screened at days 7, 14, 21, 28, and 35 for the presence 
of a cobblestone area, defined as colonies of at least five non-refractile cells growing 
beneath the stromal layer.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 99 
Results 
 
Over-expression of p107 in congenic cells 
In order to assess whether the overexpression of p107 affects HSC numbers, I first 
overexpressed the gene in young unmanipulated congenic mice .  Vectors (empty vector 
control/GFP+ and p107/GFP+) were transfected into Phoenix cells and viral supernatant 
was harvested after 24 and 48 hours.  Once the viral supernatant was obtained, bone 
marrow cells were harvested from congenic mice that received 5-FU four days prior to 
sacrifice.  Bone marrow cells were placed on a transwell and the viral supernatant was 
applied to the cells for 48 hours.  New supernatant was added approximately every 12 
hours, and after 48 hours the cells were injected into sub-lethally irradiated recipients 
(Figure 4.1).  Based on results obtained in neural stem cells, we hypothesized that over-
expression of p107 would decrease stem cell numbers.  However, since p107 has been 
reported to regulate cell proliferation in response to stress (Kondo et al., 2001; 
Voorhoeve et al., 1999), I hypothesized that overexpression of p107 in cells exposed to 
radiation would cause the cells to undergo cell cycle exit, thus facilitating the repair of 
DNA damage, and ultimately preserving the long-term function of the cells.  Proper cell 
cycle control and exit in the HSC compartment in times of stress and throughout the 
lifespan of the animal would ensure preservation of the HSC pool and contribute to 
decreased aging of this population in B6 mice.  Thus, a subtle increase in p107 
expression throughout the lifetime of an individual may help to preserve the primitive 
HSC compartment.  I first made sure that the sorted p107/GFP+ cells were in fact 
overexpressing p107 compared to the empty vector control at both transcript and protein 
levels.  I found that p107 transcript and protein expression was higher in cells transduced 
with p107/GFP+ compared to those transduced with the empty vector control (Figure 
4.2).  After verifying that the congenic cells overexpress p107 compared to empty vector 
control cells, p107/GFP+ cells were sorted and used for in vitro CAFC assays.  In this 
assay, primitive stem cells migrate beneath a pre-extablished stromal layer and form 
colonies (cobblestones) at various time-points over a period of a month or more.   
Cobblestones are defined as a cluster of at least five non-refractive cells growing beneath 
the stromal layer.  The longer the latency for a cobblestone to appear, the more primitive 
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in nature the cell.  Thus the frequency of long term repopulating stem cells correlates 
with the frequency of CAFC day35 cells whereas more committed progenitor cells 
correspond to CAFC day21 and day28 cells (Figure 4.3).  To our surprise, we observed a 
statistically significant two-fold increase in the frequency of CAFC day35 cells in cells 
overexpressing p107 (1.79 ± 0.31 per 100, 000 GFP+ cells) compared with cells that 
expressed the empty vector control (0.8 ± 0.14 per 100, 000 GFP+ cells) (P = 0.001)  
(Figure 4.4).  We also observed a statistically significant increase in day21 (6.44 ± 0.75) 
and day28 (2.93 ± 0.42) CAFCs in cells overexpressing p107 compared to those 
overexpressing the empty vector control (3.82 ± 0.43 and 1.44 ± 0.20, respectively) (P ≤ 
0.001).  The increase in CAFC frequency in progenitor (day21 and day28 CAFC) as well 
as stem (day35 CAFC) cells, suggests that p107 plays an important role in regulating cell 
proliferation throughout various stages of hematopoiesis.   
 
Overexpression of Snx5 in congenic cells 
      Similar to experiments with p107, I first overexpressed Snx5 in young unmanipulated 
congenic mice.  According to microarray experiments and RT-PCR, Snx5 expression is 
elevated in old B6 stem cells compared to old congenic cells.  Since old B6 mice have 
higher numbers of HSCs compared to old congenic mice, I hypothesized that the 
overexpression of Snx5 in congenic cells would increase HSC frequency in these mice.  
Vectors (empty vector control/GFP+ and Snx5/GFP+) were transfected into Phoenix cells 
and viral supernatant was harvested after 24 and 48 hours.  Viral supernatant was added 
to bone marrow cells harvested from congenic mice that received 5-FU four days prior to 
sacrifice.  The bone marrow cells were placed on a transwell and the viral supernatant 
was applied to the cells for 48 hours and new supernatant was added approximately every 
12 hours.  Finally, infected cells were injected into sub-lethally irradiated mice, which 
served as in vivo “incubators” to expand the GFP+ cell population.  After 12 weeks, the 
recipient mice were sacrificed and GFP+ cells (empty vector control and Snx5/GFP+) 
were sorted and used for the in vitro CAFC assay.  A period of 12 weeks post transplant 
allows time for the establishment of stem and progenitor cell populations in vivo.  After 
this length of time, donor contributions to all hematopoitic compartments is maximized 
and derived from stem cells originally present in the donor marrow.  Before performing 
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CAFC assays, I first measured Snx5 mRNA and protein levels in sorted empty vector 
control/GFP+ and Snx5/GFP+ cells.  I found that Snx5 mRNA and protein expression 
were higher in Snx5/GFP+ cells compared to the control vector (Figure 4.5) and 
proceeded to perform CAFC assays.  In agreement with my hypothesis, I found a 
significant increase in the frequency of day35 CAFCs in cells overexpressing Snx5 (1.17 
± 0.13 per 100,000 GFP+ cells) compared to cells expressing the empty vector (0.77 ± 
0.13 per 100,000 GFP+ cells) (P ≤ 0.05) (Figure 4.5).  I also observed a significant 
increase in the number of day14 (20.8 ± 2.07) and day21 (5.26 ± 0.50) CAFCs in cells 
overexpressing Snx5 compared to cells expressing the empty vector (13.59 ± 1.91 and 
3.86 ± 0.39, respectively) (P ≤ 0.05) (Figure 4.6).  The fact that I did not detect a 
difference in the number of day28 CAFCs can probably be explained by the fact that the 
cumulative results are from 4 individual experiments, two of which involved sorting 
Snx5/GFP+ cells and empty vector control/GFP+ cells on separate days.  It is best to sort 
the test gene cells and the control cells on the same day so that they are exposed to the 
exact same stromal cell layers and so that they can be counted on the same day.  
However, due to flow cytometer sorting schedules and time constraints this was not 
always possible, and thus likely influenced the CAFC results when the experiments were 
combined.  For the two experiments in which Snx5/GFP+ and empty vector 
control/GFP+ cells were sorted together, I observed a significant increase in day14, 
day21, day28, and day35 CAFCs in cells overexpressing Snx5 compared to those 
overexpressing the empty vector.  Thus it is likely that Snx5 increases cell number 
exclusively in stem and progenitor populations, but not in committed cell types, such as 
day7 CAFCs.              
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Discussion 
 
 Upon confirming the differential expression of p107 and Snx5 between young and 
old B6 and congenic Lin- and LSK cells, I next used recombinant retroviruses containing 
p107 and Snx5 cDNA to overexpress the genes in congenic bone marrow cells to further 
validate the genes as candidate regulators of HSC aging and/or sensitivity to irradiation. 
It must be noted that the radiation sensitivity phenotype was discovered serendipitously, 
thus the gene(s) that regulates this trait may or may not be the same gene(s) that regulates 
the stem cell aging phenotype.  Upon performing in vitro CAFC experiments, I 
demonstrated that p107 and Snx5 do in fact regulate the number of HSCs in chromosome 
2 congenic mice.   I found that the individual overexpression of p107 and Snx5 in young 
congenic bone marrow cells resulted in a statistically significant increase in the number 
of day35 CAFC cells compared to cells overexpressing the control vector.  These 
findings provide strong evidence that p107 and Snx5 positively regulate HSC number and 
suggest that elevated expression of these genes in HSCs throughout the lifespan of mice 
may affect the rate at which their HSCs age as well as affect HSC sensitivity to cellular 
stressors.  For these experiments I singly overexpressed p107 and Snx5 in congenic bone 
marrow cells.  It will be interesting in future experiments to determine if the dual 
overexpression of p107 and Snx5 in the same cells leads to a further increase in stem cell 
number compared to the present studies where the genes were individually expressed.  
Additionally, although the data is not available at the time of dissertation writing, I am 
performing CRU assays in vivo in which graded doses of donor Snx5 and p107 
overexpressing cells are injected into lethally irradiated, but genetically distinguishable, 
recipient mice along with a set number of competitor cells.  These experiments will allow 
me to calculate the absolute frequency of Snx5 and p107 overexpressing cells compared 
to cells expressing the empty vector in recipient mice, and thus will undoubtedly reveal 
whether the genes regulate HSC number in an in vivo setting.   
 Because HSCs are extremely rare, it is not possible to obtain them in sufficient 
numbers for classical biochemical characterization.  Therefore, in order to facilitate 
functional studies of the hematopoietic system, retroviral gene transfer techniques serve 
as useful tools.  Enhanced gene transfer techniques such as pre-treatment of donor 
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animals with 5-FU, the use of cytokines, and the use of selectable markers that allow for 
the distinction between transduced and non-transduced cells have greatly improved the 
efficiency of this technique in HSCs.  Treatment of donor animals with 5-FU prior to 
bone marrow harvest forces primitive cells into cycle and thus facilitates retroviral gene 
transfer into HSCs.   Additionally, pre-stimulation of donor marrow cells from 5-FU 
treated mice with IL-3, IL-6, and SCF further enhances gene transfer into HSCs.  Studies 
have shown that SCF synergizes with other cytokines to promote the survival of primitive 
cells during in vitro manipulations associated with retroviral infection (Luskey et al., 
1992).  Even though the use of these techniques enhances retroviral gene transfer into 
HSCs, the efficiency of gene transfer is never 100% and thus it is necessary to have a 
way to assess infection efficiency in HSCs.  In my studies, GFP served as a selectable 
marker to track transduced cells which were then isolated by flow cytometry and used in 
subsequent CAFC functional assays.     
In the present study, I overexpressed p107 in primary congenic hematopoietic 
bone marrow cells and performed in vitro CAFC assays to assess the role of p107 in 
regulating HSC numbers.  Surprisingly, I found that the overexpression of p107 resulted 
in a significant increase in the frequency of CAFC day21, day28, and day35 cells 
compared to empty vector controls.  Based on studies performed by Vanderluit et al., I 
expected to see a decrease in the frequency of CAFC day35 cells, especially since the 
cells used in the assay had not been exposed to any overt replicative stress.  I originally 
hypothesized that overexpression of p107 in bone marrow cells exposed to irradiation 
(i.e. cellular stressor) would force them to arrest at G1, thus allowing cells time to repair 
damage, enter a senescent state, or undergo apoptosis.  Over the lifetime of the animal, 
this intact cell cycle checkpoint would prevent DNA damage accumulation in the stem 
cell compartment and thus would ensure long-term function of the hematopoietic system.  
In contrast, congenic cells may proceed through the cell cycle, thus resulting in the 
accumulation of DNA damage in the congenic HSC pool.  The accretion of damaged 
cells may ultimately result in impaired function of congenic HSCs in old mice (Figure 
4.6). 
Daria et al. recently investigated the function of pRb in hematopoiesis by creating 
an animal model in which floxed pRb alleles were deleted in the hematopoietic 
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compartment by Cre recombinase driven by the Vav1 promoter (Daria et al., 2008).   In 
the absensce of pRB there was a significant decrease in the frequency of CAFC day35 
cells.  They went on to perform competitive transplant experiments with Vav-Cre Rb KO 
cells, and observed a 8-fold reduced contribution to chimerism in peripheral blood 
compared with control cells.  Since they found identical numbers of HPCs and HSCs in 
Vav-Cre Rb KO bone marrow and control bone marrow, they reasoned that pRb was a 
regulator of hematopoietic stem and progenitor cells under conditions of stress, such as 
transplantation and 5-FU treatment.  Based on our observations with p107 in 
hematopoietic cells, we propose that the cell sorting procedure and the CAFC assay itself 
may serve as efficient stressors to trigger retinoblastoma family protein-mediated cell 
cycle exit and arrest.  Indeed, it is well established that primitive HSCs in the bone 
marrow reside in a hypoxic microenvironment and that low oxygen levels play a role in 
the maintenance of normal stem cell function (Cipolleschi et al., 1993; Danet et al., 2003; 
Parmar et al., 2007).  The CAFC assay was performed in 5% humidified incubators in 
normoxic conditions (20% O2), whereas in vivo HSCs are maintained in hypoxic (< 3% 
O2) conditions.  This oxygen imbalance likely imparts additional stress on primitive 
HSCs.   
To my knowledge, extensive analysis of the function of the closely related pRb 
gene, p107, has never been performed in the HSC compartment. LeCouter et al. did 
however report a myeloproliferative disorder as well as extensive extramedullary 
hematopoiesis in the spleen and liver (which was predominantly myeloid in composition) 
in germ line mutated p107-/- BALB/cJ mice (LeCouter et al., 1998).  They also observed 
increased numbers of myeloid progenitor cells in the femurs of p107-/- mice, consistent 
with results of Daria et al. (Daria et al., 2008).  Although LeCouter et al. reported a less 
severe phenotype when p107-/- mice were backcrossed to a B6 background, they did not 
look closely at individual organ systems and certainly did not assess the phenotype in 
response to conditions of stress.  I propose that in addition to pRB, p107 plays an 
important role in regulating HSCs.   I further hypothesize that hematopoietic stem cells 
are very sensitive to situations in which they are removed from their natural environment 
and p107 may play a role in sensing this stress.  Perhaps this is a protective mechanism 
that HSCs have acquired in order to preserve the function and integrity of this vital cell 
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population. Further, the elevated expression of p107 in B6 LSK cells may serve to protect 
these cells from the damaging effects of low dose irradiation.  The cells elicit proper cell 
cycle checkpoints and are able to preserve the integrity of their population over time.   
Cogenic LSK cells, on the other hand, may continue to cycle and therefore accumulate 
cells with damaged DNA. Ultimately this scenario may result in impaired self-renewal 
capacity and diminished numbers of HSCs over the life span of an organism.     
Numerous studies have assessed the role of the closely related protein, pRB, in 
the hematopoietic compartment (Daria et al., 2008; Lee et al., 1992; Spike et al., 2004; 
Spike and Macleod, 2005).  Spike et al. demonstrated cell intrinsic defective erythroid 
maturation under stress conditions in Rb-/- cells as well as the loss of hematopoietic stem 
and progenitor cells from the bone marrow and spleen of mice transplanted with Rb-/- 
fetal liver cells. An additional study conducted by Spike et al., showed that Rb null 
erythroblasts contained increased levels of reactive oxygen species (ROS), greater levels 
DNA damage, as well as altered chromosome structure compared to wild-type cells 
(Spike and Macleod, 2005).    These data suggests that the Rb, and perhaps additional 
pocket protein members, is required for hematopoietic homeostasis.  Moreover, my 
studies with p107 suggest that increased levels of these proteins may increase stem cell 
number, although the mechanism of this function is not yet known.  I am currently 
performing an extensive in vivo analysis of the role of p107 in the HSC compartment.   
CRU experiments with cells overexpressing p107 are being conducted in order to 
determine if elevated expression of the gene corrects the early stem cell aging phenotype 
observed in D2 and congenic mice.    
The fact that p107 contains four SNPs resulting in amino acid substitutions 
provides additional strength supporting our hypothesis that p107 is a QT gene that 
regulates HSC aging because the exonic SNPs may explain differential p107 expresssion 
in B6 and congenic mice.  Rb family members contain a common region know as a 
“pocket” which consists of two conserved domains, A and B, and a non-conserved spacer 
region (Chow et al., 1996).    Starostik et al. have shown that the central pocket in p107, 
including domains A and B, but not the spacer region, is sufficient for p107 to act as a 
general cellular repressor as well as its ability to inactivate E2F (Starostik et al., 1996).   
Additional studies have shown that the spacer region in p107 mediates an interaction with 
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the cell cycle regulatory protein cyclin A, thus providing p107 with dual interaction 
domains (Ewen et al., 1992; Faha et al., 1992; Smith and Nevins, 1995; Zhu et al., 1995).  
Mutations in these regions critical for p107 function, although not causing differential 
expression of the gene, could interfere with the normal functioning of the protein and 
thus render cells more vulnerable to cellular stressors.  
Snx5, the other candidate gene in these studies, has been shown to bind to the 
FANCA protein and its knock down in zebrafish was shown to lead to an 80% reduction 
in circulating blood cell production, thus making it an attractive potential regulator of 
HSC function.  Similar to studies performed with p107, I overexpressed Snx5 in congenic 
bone marrow cells and performed in vitro CAFC assays to determine whether Snx5 
affected the frequency of HSCs.  According to microarray, real time PCR and western 
blot data, Snx5 expression is elevated in young and old B6 HSCs compared to young and 
old congenic HSCs.  Because the number of primitive HSCs increases in B6 mice as they 
age, I hypothesized that Snx5 was a positive regulator of HSC number and that its 
overexpression in congenic bone marrow cells would increase HSC frequency.   Upon 
performing CAFC assays, I found a significant increase in the frequency of day14, day21, 
and day35 CAFCs in congenic HSCs overexpressing Snx5 compared to cells expressing 
the control vector.  As explained previously, the reason I did not see an increase in the 
number of day28 CAFCs in cells overexpressing Snx5 is likely due to the fact that in two 
of the replicate assays, Snx5 overexpressing cells and empty vector control cells were not 
isolated on the same day.  This added technical variability to these studies, which could 
have been avoided if the test cells were sorted at the same time.  In two of the four 
individual CAFC experiments, Snx5/GFP+ and empty vector control/GFP+ cells were 
sorted on the same day.  Upon combining these data, I observed a significant increase in 
day14, day21, day28, and day35 CAFCs in cells overexpressing Snx5 compared to those 
overexpressing the empty vector.  These data suggest that elevated Snx5 expression 
affects HSC frequency specifically in stem and progenitor cells and not in differentiated 
cells and thus further validates our hypothesis that Snx5 may regulate the HSC aging 
trait.   
The CAFC results reinforce our hypothesis that overexpression of Snx5 increases 
HSC number and suggest that the life-long elevated expression of Snx5 in B6 HSCs may 
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help the cells respond to and repair DNA damage more efficiently than congenic HSCs.  
This enhanced DNA repair capacity, possibly due to Snx5’s interaction with FANCA 
and/or EGFR, may slow the aging of the cells and possibly increase their self-renewal 
capacity which leads to an increase in HSC number with advancing age (Figure 4.7).  
Unlike p107, Snx5 does not have any non-synomous coding region SNPs between 
B6 and D2 mice.  According the Ensembl genome browser, the gene does however have 
8 3’UTR and 8 intronic SNPs.  It is possible that the intronic SNPs could affect transcript 
stability of thus expression of Snx5 mRNA.  Also, due to the presence of 7 predicted 
murine microRNA binding sites in the 3’ UTR of Snx5, it is possible that SNPs located in 
the 3’ UTR may modulate Snx5 expression.   
   The fact that Snx5 has been shown to interact with two proteins that are 
involved in mediating DNA repair processes is intriguing.  The overexpression of Snx5 in 
293 cells was shown to increase levels of the FANCA protein in a dose dependent 
manner (Otsuki et al., 1999).  Similarly, upon overexpressing Snx5 in a NR6/EGFR cell 
line, EGFR expression was induced and maintained thus suggesting reduced degradation 
of the receptor during EGFR signaling (Liu et al., 2006).  As mentioned previously, 
FANCA is one of eleven Fanconi anemia genes that collectively function to regulate how 
cells recognize and repair DNA damage (Mathew, 2006).  Cells (such as B6 HSCs) that 
express high levels of Snx5 may also express high levels of FANCA, thus increasing the 
DNA repair capacity and enhancing the longevity of these cells.   Like FANCA, EGFR 
has also been implicated in DNA repair pathways.  EGFR is a cell surface receptor that 
mediates cell proliferation, migration and survival.  EGFR is frequently expressed in 
cancers of epithelial origin, and its expression and activity correlate with tumor resistance 
to radiotherapy (Chen and Nirodi, 2007).  Recent studies show that EGFR plays a 
radioprotective role which involves translocating to the nucleus and binding to and 
activating DNA-PK, which then mediates NHEJ to repair DNA double stranded breaks 
(Bandyopadhyay et al., 1998; Dittmann et al., 2005; Lin et al., 2001).  Since Snx5 has 
been shown to stabilize and prevent the degradation of EGFR, it is possible that increased 
Snx5 expression enhances DNA repair capacity through the NHEJ repair pathway as 
well.  Snx5 may be working through both the FANC and the DNA-PK/NHEJ DNA repair 
pathways to help protect the accumulation of damage in B6 HSCs.  Reduced expression 
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of Snx5 in congenic HSCs throughout the lifespan of the animal may reduce the ability of 
the cells to respond to and repair DNA damage, which ultimately leads to a qualitative 
and quantitative decline the in their hematopoietic system with age.   
In summary, I have identified p107 and Snx5 as quantitative trait genes that 
regulate the number of HSCs in B6 and congenic mice.  CAFC assays confirmed that 
increased expression of both genes increases HSC number in an in vitro setting.  
Although the increased expression of both Snx5 and p107 resulted in small increases in 
HSC number, the changes are biologically significant given the extensive proliferative 
potential of primitive stem cells.  Extemely small fluctuations in the size of the HSC pool 
can result in dramatic differences in mature blood cell production, and thus immune 
function, due to the fact that HSCs are the sole source of all differentiated blood cells.   
In vivo CRU assays will be performed in future experiments to unequivocally 
demonstrate that these genes regulate HSC numbers.  I hypothesize that long term 
elevated expression of the genes protects the HSC pool and thus ultimately slows the 
aging of the cells and possibly the entire individual.  
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Figure 4.1 Schematic illustrating the experimental design used for retroviral 
transduction of HSCs.  The Sfbeta 91 retroviral vector served as the backbone for p107 
and Snx5 cDNA-containing vectors as well as an empty vector control.  Phoenix 
packaging cells were transfected with the vectors and high titer viral supernatant was 
collected after 24 and 48 hours.  Bone marrow cells were harvested from young congenic 
mice that had been injected intraperitoneally with 150 mg per kg of body weight of 5-FU 
4 days prior to harvest.  The bone marrow cells were placed on a transwell insert (in a six 
well plate) and were exposed to the viral supernatant for 2 days.  Infected cells were then 
injected into sub-lethally irradiated B6 recipient mice.  Twelve weeks post 
transplantation, GFP+ cells were sorted and used for in vitro CAFC assays. 
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Figure 4.2 Overexpression of p107 in transduced HSCs. Real time PCR data showing 
that p107 mRNA levels are elevated in primary GFP+ cells compared to cells infected 
with the empty vector control (P ≤ 0.01) Results are given as mean ± SEM, n = 8 
measurements from 2 individual experiments.   Representative western blot showing 
overexpression of p107 protein in sorted GFP+ bone marrow cells (B). 
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Figure 4.3 Diagram of the cobblestone area forming cell (CAFC) assay. 
The CAFC assay is in an in-vitro limiting dilution assay to measure HSC number.  Stem 
and progenitor cells of a particular developmental stage migrate beneath a stromal cell 
layer and form cobblestone-like colonies.  Cobblestone formation is assessed at various 
days after plating and the maximum likelihood analysis is used to determine stem cell 
number.  The longer the latency before a cell proliferates and forms a cobblestone area, 
the more primitive in nature the cell. 
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Figure 4.4 CAFC numbers in congenic cells overexpressing p107 and the empty 
vector control.  I observed a statistically significant two-fold increase in the frequency of 
day35 CAFCs in cells overexpressing p107 compared with cells that expressed the empty 
vector as well as a significant increase in day21 and day28 CAFCs in cells 
overexpressing p107 compared to those overexpressing the empty vector control (P ≤ 
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0.001) (A).  Closer view of day 21, day 28, and day 35 CAFC numbers in young 
congenic bone marrow cells overexpressing p107 or empty vector control (B). Results are 
given as mean ± SEM, n = 4 replicate experiments.  
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Figure 4.5 Overexpression of Snx5 in transduced HSCs. Real time PCR data showing 
that Snx5 mRNA levels are elevated in primary GFP+ cells compared to cells infected 
with the empty vector control (P ≤ 0.01) Results are given as mean ± SEM, n = 12 
measurements from 3 individual experiments (A).   Representative western blot showing 
overexpression of Snx5 protein in sorted GFP+ bone marrow cells (B). 
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Figure 4.6 CAFC numbers in congenic cells overexpressing Snx5 and the empty 
vector control.  I observed a statistically significant increase in the number of day14, 
day21 and day35 CAFCs in cells overexpressing Snx5 compared to those overexpressing 
the empty vector conrol (P ≤ 0.05) (A).  Closer view of day21, day28 and day35 CAFC 
numbers in congenic cells overexpressing Snx5 and the empty vector (B). Results are 
given as mean ± SEM, n = 4 replicate experiments. 
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Figure 4.7 Mechanism by which p107 may regulate HSC number 
B6 bone marrow cells, which express high levels of p107, may undergo cell cycle arrest 
after exposure to irradiation, thus allowing cells time to repair damage, enter a senescent 
state, or undergo apoptosis.  Over the lifetime of the animal, this intact cell cycle 
checkpoint would prevent DNA damage accumulation in the B6 stem cell compartment.  
In contrast, the congenic cells, which express low levels of p107, may proceed through 
the cell cycle after the insult, thus resulting in the accumulation of DNA damage in the 
congenic HSC pool.  The accretion of damaged cells may ultimately result in impaired 
function of congenic HSCs in old mice. 
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Figure 4.8 Mechanisms by which Snx5 may regulate stem cell number.  
Snx5 interacts with both FANCA and EGFR, two genes involved in DNA repair 
pathways.  Snx5 may serve to increase or stabilize FANCA and EGFR expression, 
thereby facilitating enhanced DNA repair capacity in stem cells.  Enhanced DNA repair 
capacity throughout the lifespan of an organism may protect HSCs from accumulating 
DNA damage and thus slow the aging process in these cells. 
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CHAPTER FIVE 
 
General Discussion and Conclusions 
 
Despite their ability to self-renew and maintain essentially normal levels of 
hematopoietic function throughout the lifetime of an organism, it has become 
increasingly evident that hematopoietic stem cells (HSCs) are subject to qualitative and 
quantitative changes and that these changes may affect both the rate of aging and 
longevity of organisms.  The main goal of my dissertation study was to evaluate the 
hypothesis that one or more genes located in a QTL on murine chromosome 2 contributes 
to the strain specific difference in the frequency of HSCs in aged C57BL/6 (B6) and 
DBA/2 (D2) mice.  However, in a broader sense, the ultimate goal of my research was to 
identify genes in a murine mouse model that could one day be extended to human HSCs, 
thus contributing to the understanding of the complex biology of HSC aging.   
Following a classical forward genetic approach, I proposed three specific aims to 
explore the aforementioned hypothesis: 1) to better understand the mechanistic basis for 
the different number of HSCs in aged B6 and congeic mice by determining the cell cycle, 
apoptotic, and self-renewal status of HSCs using a surrogate assay to mimic aging; 2) to 
identify differentially expressed genes between B6 and congenic mice that may 
contribute to the HSC aging phenotype using microarray technology; 3) to overexpress 
candidate gene(s) uncovered in the microarray analysis and determine their effect on 
HSC number and function.   
Novel findings in this dissertation include the discovery that D2 alleles in the 
chromosome 2 QTL affect the level of apoptosis and the self-renewal capacity of HSCs.  
Specifically, D2 alleles decreased the percentage of lineage negative (Lin-) cells 
undergoing apoptosis following 2 Gy of irradiation and drastically decreased the self-
renewal capacity of HSCs exposed to 2 Gy of irradiation as revealed by serial 
transplantation experiments.   In addition, microarray studies identified two novel 
candidate genes that may regulate HSC aging, Retinoblastoma like protein 1 (p107) and 
Sorting nexin 5 (Snx5).  B6 alleles are associated with upregulated p107 and Snx5 
expression as well as increased HSC number in aged mice, therefore I hypothesized that 
 119 
both genes are positive regulators of HSC number.  Further, cobblestone area forming 
cell assays (CAFC) revealed that p107 as well as Snx5 increased the frequency of day35 
CAFCs, which correspond to primitive HSCs.  Therefore these studies not only reveal the 
power of combining classic QTL studies with modern microarray technologies to identify 
genes underlying complex quantitative traits, but also provide strong evidence that p107 
and Snx5 may regulate some aspect of HSC aging.  
Unfortunately these studies cannot definitely determine whether p107 and Snx5 
control the HSC aging phenotype or the sensitivity to low dose irradiation.  It is possible 
that the genes control both of the traits and that our surrogate assay to measure aging 
activates the same molecular pathways that are at work in aged stem cell populations.  
Indeed, my microarray studies showed significant overlap in the age and irradiation 
treatment probesets, suggesting that irradiation damage causes similar transcriptional 
changes as does the natural aging process.  I am in the process of expanding my aged 
congenic colony, and future experiments will be performed in which p107 and Snx5 will 
be overexpressed in aged congenic cells.   If I obtain similar results as observed in young 
congenic cells, I will conclude that the genes do in fact regulate the number of HSCs in 
old mice.  In addition, performing self-renewal assays with old B6 and congenic cells will 
allow for me to determine whether on not increased self-renewal capacity is the 
mechanism by which B6 HSCs increase in number with age.  Also, performing CAFC 
experiments with transduced congenic cells that have been irradiated will determine 
whether the genes affect HSC response to cellular stressors.  Nonetheless, these current 
studies do in fact indicate that elevated expression of p107 and Snx5 increase the number 
of day35 CAFC numbers, which correspond to primitive stem cells.   
In light of recent data suggesting that DNA damage accumulation throughout the 
long lifespan of HSCs contributes to their decline in cellular function with age, the fact 
that p107 and Snx5 may regulate the response to and/or the repair of DNA damage makes 
them great candidates for regulating the complex biology of HSC aging.  p107 
participates in mediating cell cycle arrest in response to stress, which in turn allows cells 
time to repair damage and proceed through the cell cycle or alternatively,  undergo 
apoptosis.  Indeed, p107 may help prevent the accumulation of DNA damage in HSCs, 
therefore preserving their function in old age.  Moreover, the mechanistic phenotypes of 
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the congenic cells, including reduced apoptosis in Lin- cells and a subtle but non-
significant increase in LSK cell cycling may result from the decreased expression of p107 
in these mice.   Reduced levels of p107 expression are consistent with increased cycling 
as well as the inability to exit cycle and undergo apoptosis in response to DNA damage in 
the form of irradiation.  Like p107, Snx5 may also be involved, through FANCA or 
EGFR, in the regulation of HSC response to and repair of DNA damage, and thus may 
prevent the accumulation of DNA damage in HSCs.  Reduced levels of Snx5 in congenic 
HSCs may compromise their ability to repair DNA damage, which may contribute to the 
profound decrease in self-renewal capacity of these cells in response to irradiation.  To 
my knowledge there is no available data linking the cellular pathways of p107 and Snx5, 
however it is possible that the two genes work in the same pathway to regulate HSC 
number.  The underlying mechanisms by which p107 and Snx5 control HSC pool size 
must be resolved in order to determine whether the genes may act together to effect stem 
cell number.       
 In conclusion, although the clinical applications of these findings may be far 
away, my studies have identified two novel regulators of HSC number and thus bring us 
one step closer toward understanding the genes and molecular pathways that regulate 
stem cell number as well as stem cell aging and response to stress.  However, as 
mentioned previously, more experiments need to be performed in order to determine the 
exact context in which p107 and Snx5 regulate HSC number.   In addition to the 
aforementioned experiments, I will examine the effects of the knock-down of p107 and 
Snx5 using morpholino technology to help validate them as candidate genes.   I 
hypothesize that performing CAFC assays with cells in which p107 and Snx5 have been 
knocked-down will decrease the frequency of day35 CAFCs.  Ultimately, I would like to 
expand these findings to human HSC biology in order to determine whether the 
expression of p107 and Snx5 regulate human stem cells.  Hopefully, these studies will aid 
in the development of HSC amplification strategies, which will expand the use of these 
cells in transplantation procedures for the treatment of hematological diseases.  For 
example, the overexpression of p107 and Snx5 may be able to expand a cancer patient’s 
normal HSCs for use in autologous stem cell transplants.   Overexression of the genes in 
normal stem cells may be able to increase the number of the patient’s HSCs which could 
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then be reintroduced to the patient after high dose chemotherapy and/or radiation 
treatment.  The reintroduced cells would function to restore or rescue hematologic and 
immunologic function following high dose therapy.  This procedure would not only 
reduce the number of cells necessary for the initial harvest, but would also eliminate the 
need to locate allogenic donors which are often difficult to find.  Stem cell therapies to 
treat various cancers have advanced greatly in past several years.  It is my hope that the 
research performed in this dissertation will aid in the advancement and use of such 
therapies.   
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